syndrome	score	normalized_score
MIRAGE SYNDROME; MIRAGE	0.537880882	100.0
CHOPS SYNDROME; CHOPS	0.500843882	93.11427469548917
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.184752282	34.34817785548288
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.178333212	33.154777938361455
Growth hormone deficiency, isolated, type IA	0.1761903	32.75637894860149
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.175427192	32.61450590095522
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.17502379999999998	32.539509370403685
PEROXISOME BIOGENESIS DISORDER 11B	0.16778059	31.19288965544606
HOLOPROSENCEPHALY 7	0.167510882	31.142746954891777
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.166667	30.98585682768328
FRYNS MICROPHTHALMIA SYNDROME	0.166667	30.98585682768328
IMMUNODEFICIENCY 15A; IMD15A	0.166667	30.98585682768328
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.166667	30.98585682768328
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.166667	30.98585682768328
TELECANTHUS	0.166667	30.98585682768328
#615592 IMMUNODEFICIENCY 15; IMD15	0.166667	30.98585682768328
KABUKI SYNDROME 1	0.16337231199999996	30.373325668786265
FONTAINE PROGEROID SYNDROME; FPS	0.16048205	29.835983276312096
#173100 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2;;IGHD II;;GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL DOMINANT;;PITUITARY DWARFISM DUE TO ISOLATED GROWTH HORMONE DEFICIENCY, AUTOSOMALDOMINANT	0.16009839999999997	29.76465707513285
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.16009839999999997	29.76465707513285
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.1577824	29.33407846981258
GAUCHER DISEASE, TYPE II	0.14688559199999998	27.308200926167142
MARSHALL-SMITH SYNDROME; MRSHSS	0.14397058999999998	26.766259002304526
OROFACIODIGITAL SYNDROME VIII; OFD8	0.14370088199999997	26.716116301750244
OROFACIODIGITAL SYNDROME IX; OFD9	0.14370088199999997	26.716116301750244
PITUITARY DWARFISM IV	0.14285699999999998	26.559226174541745
PANHYPOPITUITARISM, X-LINKED	0.14285699999999998	26.559226174541745
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.14285699999999998	26.559226174541745
ALSTROM SYNDROME; ALMS	0.12095969200000001	22.488193213009573
RHEUMATOID ARTHRITIS	0.1147012	21.324647117686553
COHEN SYNDROME	0.10425913	19.38331208432874
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.099537	18.50539837554591
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.099537	18.50539837554591
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.099537	18.50539837554591
TEMPLE SYNDROME	0.09933419	18.467693001217324
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.09332233000000001	17.349999437235997
HYDROXYKYNURENINURIA	0.092755682	17.244651205134303
TUBEROUS SCLEROSIS	0.09257689999999999	17.21141299087853
GLYCOGEN STORAGE DISEASE IB	0.08612560999999999	16.01202289989552
GLYCOGEN STORAGE DISEASE VI	0.08522811	15.845164394595457
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0820434	15.25307977017856
HYPERLIPOPROTEINEMIA, TYPE I	0.0820434	15.25307977017856
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0820434	15.25307977017856
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.08156867000000001	15.16482045182636
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.080270272	14.923429087408987
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0783723	14.57056806120133
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0774254	14.394525366305919
GLYCOGEN STORAGE DISEASE IA	0.07581631	14.09537177043597
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.07581631	14.09537177043597
MARFAN SYNDROME; MFS	0.0738636	13.732334141595315
EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE	0.0738636	13.732334141595315
LICHTENSTEIN SYNDROME	0.0728093	13.536324200494636
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.0724569	13.470807835850914
SMITH-MAGENIS SYNDROME; SMS	0.071505292	13.293889854222407
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.067557	12.559844058558678
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.067108972	12.476549036371962
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0664488	12.35381331140154
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.064683602	12.02563693275122
PSEUDOTRISOMY 13 SYNDROME	0.06361359	11.826705898797869
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.063343882	11.776563198243586
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.0625	11.619673071035086
STRIAE DISTENSAE, FAMILIAL	0.0625	11.619673071035086
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0625	11.619673071035086
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.0625	11.619673071035086
FASCIAL DYSTROPHY, CONGENITAL	0.0625	11.619673071035086
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.0625	11.619673071035086
LOEYS-DIETZ SYNDROME 3; LDS3	0.0625	11.619673071035086
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0625	11.619673071035086
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0625	11.619673071035086
CHERUBISM	0.0625	11.619673071035086
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.0625	11.619673071035086
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.0625	11.619673071035086
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0625	11.619673071035086
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.0625	11.619673071035086
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.0625	11.619673071035086
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.0625	11.619673071035086
PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY	0.0625	11.619673071035086
#604308 MASS SYNDROME;;MASS PHENOTYPE;;OVERLAP CONNECTIVE TISSUE DISEASE; OCTD	0.0625	11.619673071035086
EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTINABNORMALITY	0.0625	11.619673071035086
TRIMETHYLAMINURIA	0.062448399999999994	11.610079868947638
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.062037	11.533594532924859
CORNELIA DE LANGE SYNDROME 1	0.06128302	11.393418515291273
Helsmoortel-van der Aa syndrome	0.060538272	11.254958862806356
PRIMROSE SYNDROME; PRIMS	0.060104809999999995	11.174371875146884
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.05855879	10.88694392376638
FOLATE MALABSORPTION, HEREDITARY	0.056498012	10.503814857654675
TURNPENNY-FRY SYNDROME; TPFS	0.056180242	10.444736721466148
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.05581631	10.377076387704742
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.05581631	10.377076387704742
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.05559389	10.335725224753388
AICARDI-GOUTIERES SYNDROME 7	0.055142182000000005	10.251746036216252
PRADER-WILLI SYNDROME; PWS	0.054350372	10.10453686286623
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.054278400000000004	10.091156205101933
TIMOTHY SYNDROME; TS	0.054256571999999996	10.087098057521219
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.05299143199999999	9.851889846495789
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.052806281999999996	9.817467726990156
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.0526316	9.784991763287843
#600995 NEPHROTIC SYNDROME, TYPE 2; NPHS2;;NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE; SRN1	0.0526316	9.784991763287843
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0526316	9.784991763287843
WOODHOUSE-SAKATI SYNDROME	0.0526316	9.784991763287843
#616000 ANALBUMINEMIA; ANALBA	0.0526316	9.784991763287843
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0526316	9.784991763287843
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.0526316	9.784991763287843
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0526316	9.784991763287843
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0526316	9.784991763287843
CHARGE SYNDROME	0.0521668	9.69857857859317
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.051957472000000005	9.659661411799354
JOUBERT SYNDROME 30; JBTS30	0.051957472000000005	9.659661411799354
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.051957472000000005	9.659661411799354
#170100 PROLIDASE DEFICIENCY	0.051755892	9.622184712636802
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.051374892	9.551351185595774
RAYNAUD-CLAES SYNDROME; MRXSRC	0.051164772	9.512286774304798
DYSTONIA 28, CHILDHOOD-ONSET	0.050843882	9.452628584036567
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.050843882	9.452628584036567
JOUBERT SYNDROME 23; JBTS23	0.050843882	9.452628584036567
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.050843882	9.452628584036567
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.050843882	9.452628584036567
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.05040691	9.371389035537426
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.05027467	9.346803666466808
LEBER OPTIC ATROPHY AND DYSTONIA	0.05	9.295738456828069
SPINOCEREBELLAR ATAXIA 12	0.05	9.295738456828069
HUNTINGTON DISEASE; HD	0.05	9.295738456828069
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.05	9.295738456828069
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.05	9.295738456828069
3MC SYNDROME 1	0.05	9.295738456828069
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	0.05	9.295738456828069
KURU, SUSCEPTIBILITY TO	0.05	9.295738456828069
#614815 JOUBERT SYNDROME 18; JBTS18	0.05	9.295738456828069
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.049819999999999996	9.262273798383488
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.0494118	9.186383389621943
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.0484006	8.998386375071053
ROIFMAN SYNDROME; RFMN	0.048277681999999995	8.975534103478324
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.04813421	8.948860539720762
CYSTIC FIBROSIS	0.0477273	8.873209961011405
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.047222200000000006	8.77930441112053
CASPASE 8 DEFICIENCY	0.047222200000000006	8.77930441112053
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.047183499999999996	8.772109509554943
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.046870301999999996	8.71388137569091
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.04657613000000001	8.659190456224472
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.04550379	8.45982661268857
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0449495	8.356775915303865
Prader-Willi Syndrome (Type 2)	0.04423124	8.22324077322384
Prader-Willi syndrome (Type 1)	0.04423124	8.22324077322384
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.043589222	8.10388014497232
CHROMOSOME 18Q DELETION SYNDROME	0.04335499	8.060332956767928
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.04331998199999999	8.053824452529993
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.043085282	8.010190256213644
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.042950791999999995	7.985186578912466
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.042179182	7.841732883899005
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.042179182	7.841732883899005
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.042179182	7.841732883899005
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.04196684	7.802255369991008
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.041837202	7.7781537511496825
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.041641130000000005	7.741701070535541
WITTEVEEN-KOLK SYNDROME	0.041544612	7.723756948848018
#300867 KABUKI SYNDROME 2; KABUK2	0.041409812	7.698695637968409
WHITE-SUTTON SYNDROME; WHSUS	0.041018292	7.625906287556061
HALLERMANN-STREIFF SYNDROME; HSS	0.04089362	7.602727921458269
LOWE OCULOCEREBRORENAL SYNDROME	0.0407754	7.580749077450945
IMMUNODEFICIENCY 47	0.04022171	7.477809928927721
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.04022171	7.477809928927721
Polyarteritis nodosa, childhood-onset	0.04022171	7.477809928927721
Myhre syndrome	0.0395417	7.351386026767169
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0394636	7.336866083297604
2q33.1 deletion syndrome	0.039452339999999995	7.334772682997125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.039331172	7.312245762250387
POTOCKI-LUPSKI SYNDROME	0.039228611999999996	7.29317834352774
MEHMO SYNDROME; MEHMO	0.039198872	7.2876492382936195
DESBUQUOIS DYSPLASIA 2; DBQD2	0.038994471999999995	7.249648259482106
NAVAJO NEUROHEPATOPATHY	0.038475482	7.153160353447922
MENTAL RETARDATION, X-LINKED 12; MRX12	0.03815059	7.092758132273606
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.038127532	7.088471309526856
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.037880882	7.042615431719323
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.037880882	7.042615431719323
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.037880882	7.042615431719323
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.037880882	7.042615431719323
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.037880882	7.042615431719323
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.037880882	7.042615431719323
BARATELA-SCOTT SYNDROME	0.037880882	7.042615431719323
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.037880882	7.042615431719323
DIAMOND-BLACKFAN ANEMIA 5	0.037880882	7.042615431719323
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.037880882	7.042615431719323
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.03771963	7.012636303366514
IMMUNODEFICIENCY 23; IMD23	0.037266772000000004	6.928443312844871
MEIER-GORLIN SYNDROME 6; MGORS6	0.0372414	6.923726283322337
Oliver-McFarlane syndrome	0.0372414	6.923726283322337
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.0372414	6.923726283322337
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.0371476	6.906287477977329
MYELOLYMPHATIC INSUFFICIENCY	0.037037	6.885725304510823
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.037037	6.885725304510823
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.037037	6.885725304510823
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.037037	6.885725304510823
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.037037	6.885725304510823
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.037037	6.885725304510823
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.037037	6.885725304510823
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.037037	6.885725304510823
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.037037	6.885725304510823
HERMANSKY-PUDLAK SYNDROME 9	0.037037	6.885725304510823
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.037037	6.885725304510823
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.037037	6.885725304510823
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.037037	6.885725304510823
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.03690298	6.860809007151142
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.03667329	6.818106243828165
TRICHOHEPATOENTERIC SYNDROME 1	0.036518010000000004	6.78923739847664
CHROMOSOME 9P DELETION SYNDROME	0.036056412	6.703419512872742
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.035407720000000004	6.582818089452007
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.034925399999999995	6.493147678002059
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.034925399999999995	6.493147678002059
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.034925399999999995	6.493147678002059
COFFIN-SIRIS SYNDROME 1; CSS1	0.034696062	6.45051035667782
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.034553982	6.424095586278897
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.03444689	6.404185601822525
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.034215572	6.361180169255394
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.034215572	6.361180169255394
WEAVER SYNDROME	0.034215572	6.361180169255394
TONNE-KALSCHEUER SYNDROME; TOKAS	0.034215572	6.361180169255394
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.034215572	6.361180169255394
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.034215572	6.361180169255394
MENTAL RETARDATION, X-LINKED 90	0.034215572	6.361180169255394
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.034177182	6.35404290126824
MECKEL SYNDROME, TYPE 10; MKS10	0.03409894	6.339496557901459
TRISOMY 18-LIKE SYNDROME	0.03409894	6.339496557901459
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0340909	6.3380018031576
CRANIOECTODERMAL DYSPLASIA 4	0.0340909	6.3380018031576
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0337101	6.267205459070397
ECHO VIRUS 11 SENSITIVITY	0.0333333	6.197152774059742
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	6.197152774059742
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	6.197152774059742
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	6.197152774059742
IMMUNE SUPPRESSION	0.0333333	6.197152774059742
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	6.197152774059742
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0333333	6.197152774059742
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	6.197152774059742
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.0333333	6.197152774059742
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	6.197152774059742
MYELOPEROXIDASE DEFICIENCY	0.0333333	6.197152774059742
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	6.197152774059742
BLOOD GROUP, DUFFY SYSTEM; FY	0.0333333	6.197152774059742
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	6.197152774059742
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	6.197152774059742
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	6.197152774059742
RAGWEED SENSITIVITY	0.0333333	6.197152774059742
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	6.197152774059742
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0333333	6.197152774059742
SHORT SYNDROME	0.0333333	6.197152774059742
MYASTHENIA GRAVIS; MG	0.0333333	6.197152774059742
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	6.197152774059742
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.03328039	6.187316023624725
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.03316807	6.166434076755308
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.033101981999999995	6.154147341492609
LANDAU-KLEFFNER SYNDROME	0.033101981999999995	6.154147341492609
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.033101981999999995	6.154147341492609
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.033101981999999995	6.154147341492609
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.033101981999999995	6.154147341492609
#601495 AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT	0.0330366	6.141991862056924
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.0330366	6.141991862056924
#613502 AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO BLNK DEFECT	0.0330366	6.141991862056924
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.033010682	6.137173323070442
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.03301068199999999	6.13717332307044
KLEEFSTRA SYNDROME	0.03277655	6.093644726342961
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.032596509999999995	6.060172631307613
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.032596509999999995	6.060172631307613
LYSOSOMAL ACID LIPASE DEFICIENCY	0.032596509999999995	6.060172631307613
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.032596509999999995	6.060172631307613
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.032596509999999995	6.060172631307613
GLYCOGEN STORAGE DISEASE IXA	0.032596509999999995	6.060172631307613
BREATH-HOLDING SPELLS	0.0322581	5.99725721428411
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.0322581	5.99725721428411
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0322581	5.99725721428411
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0322581	5.99725721428411
HISTIDINEMIA	0.0322581	5.99725721428411
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0322581	5.99725721428411
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.0322581	5.99725721428411
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.0322581	5.99725721428411
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0322581	5.99725721428411
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.0322581	5.99725721428411
CRI-DU-CHAT SYNDROME	0.032054479999999996	5.959401248992523
CHROMOSOME 2q37 DELETION SYNDROME	0.032036802	5.956114647703728
Pierpont syndrome	0.032036802	5.956114647703728
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.032036802	5.956114647703728
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.031369272	5.832010961861998
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.03119292	5.799224520495228
Diamond-Blackfan anemia 1	0.030717499999999995	5.710836920952323
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.03052539	5.675120834653499
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.030270272000000004	5.6276906305809185
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.030270272000000004	5.6276906305809185
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.030255682	5.624978134099215
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.030255682	5.624978134099215
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.030224052000000005	5.619097649951427
RESTRICTIVE DERMOPATHY, LETHAL	0.03011694	5.59918394719967
KNIEST-LIKE DYSPLASIA, LETHAL	0.03011694	5.59918394719967
TUBEROUS SCLEROSIS 2; TSC2	0.030076899999999997	5.591739919843442
Xq28 (MECP2) duplication	0.029992341999999998	5.576019338794793
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.029532999999999997	5.490620876910066
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.0294118	5.468088006890715
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0294118	5.468088006890715
SITOSTEROLEMIA	0.0294118	5.468088006890715
XANTHOMATOSIS, SUSCEPTIBILITY TO	0.0294118	5.468088006890715
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.0294118	5.468088006890715
LONG QT SYNDROME 13; LQT13	0.0294118	5.468088006890715
BUTYRYLCHOLINESTERASE	0.0294118	5.468088006890715
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.0294118	5.468088006890715
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0294118	5.468088006890715
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.0294118	5.468088006890715
HYPERCHOLESTEROLEMIA, FAMILIAL	0.0294118	5.468088006890715
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0294118	5.468088006890715
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0294118	5.468088006890715
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	0.0294118	5.468088006890715
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA	0.0294118	5.468088006890715
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.0294118	5.468088006890715
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.0294118	5.468088006890715
PORPHYRIA VARIEGATA	0.0294118	5.468088006890715
DYSTROPHIA MYOTONICA 2	0.0294118	5.468088006890715
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.0294118	5.468088006890715
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.0294118	5.468088006890715
ALAGILLE SYNDROME 1; ALGS1	0.0294118	5.468088006890715
PARAGANGLIOMAS 4	0.0294118	5.468088006890715
PARAGANGLIOMAS 1	0.0294118	5.468088006890715
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0294118	5.468088006890715
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0294118	5.468088006890715
PHEOCHROMOCYTOMA	0.0294118	5.468088006890715
PAROXYSMAL EXTREME PAIN DISORDER	0.0294118	5.468088006890715
#603829 VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITYTO;;VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 1; VF1	0.0294118	5.468088006890715
STIFF-PERSON SYNDROME; SPS	0.0294118	5.468088006890715
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.0294118	5.468088006890715
PARAGANGLIOMAS 3	0.0294118	5.468088006890715
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.0294118	5.468088006890715
#609622 SHORT QT SYNDROME 3; SQT3	0.0294118	5.468088006890715
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.0294118	5.468088006890715
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0294118	5.468088006890715
#603776 HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3;;FH3LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS1, INCLUDED; LDLCQ1, INCLUDED	0.0294118	5.468088006890715
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.0294118	5.468088006890715
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0294118	5.468088006890715
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.0294118	5.468088006890715
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0294118	5.468088006890715
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0294118	5.468088006890715
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0294118	5.468088006890715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.029215972	5.431680689480242
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.029028592000000002	5.396843980039432
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.028907612000000003	5.374352011269291
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.028716029999999997	5.33873408796857
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.028615412000000003	5.320027715727589
CARTILAGE-HAIR HYPOPLASIA; CHH	0.02847562	5.2940383183204505
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.028446322	5.288591387414287
TRANSALDOLASE DEFICIENCY	0.02818471	5.239953852830933
MUCOPOLYSACCHARIDOSIS, TYPE II	0.02818471	5.239953852830933
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.027869482	5.181348311985553
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.027771530000000003	5.163137588519088
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.027261822	5.06837534337203
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.027192172	5.055426379701668
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.026957472000000003	5.011792183385317
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.026957472000000003	5.011792183385317
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.026755892	4.974315484222769
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.0265151	4.929548695132838
HYPOTONIA-CYSTINURIA SYNDROME	0.026393112	4.906869324275408
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.026347672000000003	4.898421357165843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.026347672000000003	4.898421357165843
ADAMS-OLIVER SYNDROME 2; AOS2	0.026347672000000003	4.898421357165843
WIEDEMANN-STEINER SYNDROME; WDSTS	0.026347672000000003	4.898421357165843
COFFIN-SIRIS SYNDROME 6; CSS6	0.026347672000000003	4.898421357165843
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.026347672000000003	4.898421357165843
RITSCHER-SCHINZEL SYNDROME 1	0.026001592000000004	4.834079973863062
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.02591201	4.81742535701427
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.02591201	4.81742535701427
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.02591201	4.81742535701427
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.02591201	4.81742535701427
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.02591201	4.81742535701427
NETHERTON SYNDROME; NETH	0.025843882000000002	4.804759355622535
BARDET-BIEDL SYNDROME 1; BBS1	0.025843882000000002	4.804759355622535
SECKEL SYNDROME 9; SCKL9	0.025843882000000002	4.804759355622535
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.025843882000000002	4.804759355622535
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.025843882000000002	4.804759355622535
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.025843882000000002	4.804759355622535
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.025709392000000005	4.779755678321359
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.025709392000000005	4.779755678321359
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.025670619999999998	4.772547390892394
KAGAMI-OGATA SYNDROME	0.025550382	4.750193370880954
INFANTILE SIALIC ACID STORAGE DISEASE	0.025550382	4.750193370880954
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.025503790000000002	4.741531229957343
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.02540691	4.723519807123393
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.02540691	4.723519807123393
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.02540691	4.723519807123393
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.02540691	4.723519807123393
#269840 SELECTIVE T-CELL DEFECT; STCD	0.02540691	4.723519807123393
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.02540691	4.723519807123393
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.025234082	4.691388529403059
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.025234082	4.691388529403059
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.025234082	4.691388529403059
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.025234082	4.691388529403059
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.025234082	4.691388529403059
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.02515771	4.677189846654562
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.025	4.647869228414034
NEUTROPHIL CHEMOTACTIC RESPONSE	0.025	4.647869228414034
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.025	4.647869228414034
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.025	4.647869228414034
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.025	4.647869228414034
ASTHMA, SUSCEPTIBILITY TO	0.025	4.647869228414034
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.025	4.647869228414034
IGE RESPONSIVENESS, ATOPIC	0.025	4.647869228414034
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.025	4.647869228414034
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.025	4.647869228414034
ICHTHYOSIS VULGARIS	0.025	4.647869228414034
Yao syndrome	0.025	4.647869228414034
DERMATITIS, ATOPIC	0.025	4.647869228414034
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.025	4.647869228414034
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.025	4.647869228414034
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.025	4.647869228414034
IMMUNODEFICIENCY 58; IMD58	0.025	4.647869228414034
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.025	4.647869228414034
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.02481929	4.614272570483367
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.0247065	4.5933032436724535
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.024684772	4.589263687568654
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.024684772	4.589263687568654
ZECHI-CEIDE SYNDROME	0.0243902	4.53449840219456
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0243902	4.53449840219456
FEINGOLD SYNDROME 1; FGLDS1	0.0243902	4.53449840219456
FRYNS SYNDROME; FRNS	0.0243902	4.53449840219456
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.0243902	4.53449840219456
OMODYSPLASIA 1; OMOD1	0.0243902	4.53449840219456
PFEIFFER-PALM-TELLER SYNDROME	0.0243902	4.53449840219456
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0243902	4.53449840219456
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0243902	4.53449840219456
RAPADILINO SYNDROME	0.0243902	4.53449840219456
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0243902	4.53449840219456
VELOCARDIOFACIAL SYNDROME	0.0243902	4.53449840219456
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0243902	4.53449840219456
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0243902	4.53449840219456
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0243902	4.53449840219456
FETAL AKINESIA SYNDROME, X-LINKED	0.0243902	4.53449840219456
ADENYLOSUCCINASE DEFICIENCY	0.023911692	4.445536697844561
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.023911692	4.445536697844561
EHLERS-DANLOS SYNDROME, TYPE VI	0.02384089	4.432373560360155
AICARDI SYNDROME; AIC	0.02384089	4.432373560360155
GAUCHER DISEASE, PERINATAL LETHAL	0.023592909999999998	4.38627041590967
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.023571182	4.382230859805871
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.023335790000000002	4.338468010469278
TENORIO SYNDROME; TNORS	0.023335790000000002	4.338468010469278
WILLIAMS-BEUREN SYNDROME; WBS	0.02323323	4.319400591746632
CYSTINOSIS, NEPHROPATHIC; CTNS	0.02318471	4.310380007148126
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.02318471	4.310380007148126
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.02306781	4.288646570636062
ROIFMAN-CHITAYAT SYNDROME	0.023066082	4.2883253099149945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.022798102	4.238503870081779
MASP2 DEFICIENCY	0.0227273	4.225340732597371
#613500 AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGLL1 DEFECT	0.0227273	4.225340732597371
MEIER-GORLIN SYNDROME 3; MGORS3	0.0227273	4.225340732597371
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.0227273	4.225340732597371
#613494 IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4;;ANTIBODY DEFICIENCY DUE TO BAFFR DEFECT	0.0227273	4.225340732597371
NIJMEGEN BREAKAGE SYNDROME	0.0227273	4.225340732597371
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0227273	4.225340732597371
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0227273	4.225340732597371
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.0227273	4.225340732597371
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.0227273	4.225340732597371
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0227273	4.225340732597371
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0227273	4.225340732597371
LEPTIN DEFICIENCY OR DYSFUNCTION	0.0227273	4.225340732597371
ROWLEY-ROSENBERG SYNDROME	0.0227273	4.225340732597371
CILIARY DYSKINESIA, PRIMARY, 33	0.0227273	4.225340732597371
TRACHEOPATHIA OSTEOPLASTICA	0.0227273	4.225340732597371
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0227273	4.225340732597371
#612692 AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT	0.0227273	4.225340732597371
METHYLMALONIC ACIDURIA, CBLB TYPE	0.022645722	4.210174177560749
METHYLMALONIC ACIDURIA, CBLA TYPE	0.022645722	4.210174177560749
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.022572002	4.1964685407800015
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.022365672	4.158108746464055
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.022365672	4.158108746464055
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.022365672	4.158108746464055
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.022365672	4.158108746464055
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.022365672	4.158108746464055
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.022365672	4.158108746464055
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.022365672	4.158108746464055
215030 CHOLESTEROL PNEUMONIA	0.0222222	4.131435182706494
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.0222222	4.131435182706494
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.0222222	4.131435182706494
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.0222222	4.131435182706494
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0222222	4.131435182706494
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.0222222	4.131435182706494
IMMUNODEFICIENCY 32B; IMD32B	0.0222222	4.131435182706494
MUSCULAR HYPERTONIA, LETHAL	0.0222222	4.131435182706494
#600802 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,B CELL-POSITIVE, NK CELL-NEGATIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	0.0222222	4.131435182706494
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.0222222	4.131435182706494
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.0222222	4.131435182706494
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.0222222	4.131435182706494
#615561 COMPLEMENT FACTOR B DEFICIENCY; CFBD	0.0222222	4.131435182706494
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.0222222	4.131435182706494
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.0222222	4.131435182706494
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0222222	4.131435182706494
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.0222222	4.131435182706494
#615206 CARD11 IMMUNODEFICIENCY	0.0222222	4.131435182706494
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.0222222	4.131435182706494
#312863 COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX;;XCID;;IMMUNODEFICIENCY 6; IMD6	0.0222222	4.131435182706494
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0222222	4.131435182706494
#615207 IL21R IMMUNODEFICIENCY	0.0222222	4.131435182706494
IMMUNODEFICIENCY 13; IMD13	0.0222222	4.131435182706494
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.0222222	4.131435182706494
ALLAN-HERNDON-DUDLEY SYNDROME	0.02211964	4.1123677639838485
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02205261	4.099905897008624
CHROMOSOME 3q13.31 DELETION SYNDROME	0.021954219999999997	4.081613742873278
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.021954219999999997	4.081613742873278
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.021728119999999997	4.039578413571501
PROPIONIC ACIDEMIA	0.021532132	4.003141349797965
NEMALINE MYOPATHY 10	0.02152179	4.001218619255555
YUNIS-VARON SYNDROME	0.02152179	4.001218619255555
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	4.001218619255555
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	4.001218619255555
ASPARTYLGLUCOSAMINURIA; AGU	0.021410319999999997	3.9804946999399022
COSTELLO SYNDROME; CSTLO	0.021252082	3.951075918701271
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.021252082	3.951075918701271
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.021252082	3.951075918701271
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.021252082	3.951075918701271
TYSHCHENKO SYNDROME	0.021252082	3.951075918701271
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.021252082	3.951075918701271
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.021252082	3.951075918701271
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.02111359	3.925328210494011
15q26 overgrowth syndrome	0.021072340000000002	3.917659226267128
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.020843882	3.875185509939727
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.020843882	3.875185509939727
Aarskog-Scott syndrome	0.020843882	3.875185509939727
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.020843882	3.875185509939727
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02080976	3.868841726187249
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.020515312	3.814099494244527
KOOLEN-DE VRIES SYNDROME; KDVS	0.020515312	3.814099494244527
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.02042611	3.797515525008008
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	3.7941857914927715
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	3.7941857914927715
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	3.7941857914927715
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	3.7941857914927715
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	3.7941857914927715
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	3.7941857914927715
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	3.7941857914927715
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	3.7941857914927715
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	3.7941857914927715
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	3.7941857914927715
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	3.7941857914927715
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	3.7941857914927715
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	3.7941857914927715
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	3.7941857914927715
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	3.7941857914927715
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	3.7941857914927715
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	3.7941857914927715
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.020123792	3.7413101438321807
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.020123792	3.7413101438321807
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.02	3.718295382731227
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.02	3.718295382731227
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.02	3.718295382731227
OVARIAN DYSGENESIS 2; ODG2	0.02	3.718295382731227
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.02	3.718295382731227
CAMURATI-ENGELMANN DISEASE	0.02	3.718295382731227
ULNAR-MAMMARY SYNDROME; UMS	0.02	3.718295382731227
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.02	3.718295382731227
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.02	3.718295382731227
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.02	3.718295382731227
OVARIAN DYSGENESIS 7; ODG7	0.02	3.718295382731227
GITELMAN SYNDROME	0.02	3.718295382731227
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.02	3.718295382731227
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.02	3.718295382731227
#615961 ACID-LABILE SUBUNIT DEFICIENCY; ACLSD	0.02	3.718295382731227
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.02	3.718295382731227
Fabry disease	0.02	3.718295382731227
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.02	3.718295382731227
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.02	3.718295382731227
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.02	3.718295382731227
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.02	3.718295382731227
ADRENAL HYPOPLASIA, CONGENITAL	0.02	3.718295382731227
PREMATURE OVARIAN FAILURE 2B	0.02	3.718295382731227
RUVALCABA SYNDROME	0.02	3.718295382731227
NOONAN SYNDROME 7; NS7	0.019671430000000004	3.657209367036028
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.019671430000000004	3.657209367036028
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.019461012	3.61808955314385
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.019461012	3.61808955314385
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.0192237	3.573969747450515
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.019198872000000002	3.5693538555623925
JOUBERT SYNDROME 26	0.019198872000000002	3.5693538555623925
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.019198872000000002	3.5693538555623925
MACROCEPHALY/AUTISM SYNDROME	0.019180092	3.5658623761980075
OCULOSKELETODENTAL SYNDROME; OCSKD	0.018953992	3.5238270468962307
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.018906672000000003	3.5150295600206896
CHROMOSOME 16p13.2 DELETION SYNDROME	0.018906672000000003	3.5150295600206896
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.018906672000000003	3.5150295600206896
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.018906672000000003	3.5150295600206896
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.018906672000000003	3.5150295600206896
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.018906672000000003	3.5150295600206896
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.018906672000000003	3.5150295600206896
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.018906672000000003	3.5150295600206896
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.018906672000000003	3.5150295600206896
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.018906672000000003	3.5150295600206896
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.018906672000000003	3.5150295600206896
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.018906672000000003	3.5150295600206896
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.018906672000000003	3.5150295600206896
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.018906672000000003	3.5150295600206896
SHUKLA-VERNON SYNDROME; SHUVER	0.018906672000000003	3.5150295600206896
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.018906672000000003	3.5150295600206896
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.018906672000000003	3.5150295600206896
LUSCAN-LUMISH SYNDROME; LLS	0.018906672000000003	3.5150295600206896
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.018906672000000003	3.5150295600206896
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.018906672000000003	3.5150295600206896
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.018906672000000003	3.5150295600206896
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.018906672000000003	3.5150295600206896
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.018906672000000003	3.5150295600206896
KLEEFSTRA SYNDROME 2; KLEFS2	0.018906672000000003	3.5150295600206896
HYPERPROLINEMIA, TYPE I	0.018906672000000003	3.5150295600206896
Mental retardation, autosomal dominant 21	0.018906672000000003	3.5150295600206896
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	3.507821272591726
TRANSSEXUALITY	0.0188679	3.507821272591726
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	3.507821272591726
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	3.507821272591726
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	3.507821272591726
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	3.507821272591726
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	3.507821272591726
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	3.507821272591726
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	3.507821272591726
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	3.507821272591726
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	3.507821272591726
CARDIAC ARRHYTHMIA	0.0188679	3.507821272591726
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	3.507821272591726
CERVICAL RIB	0.0188679	3.507821272591726
ERYTHERMALGIA, PRIMARY	0.0188679	3.507821272591726
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	3.507821272591726
JUMPING FRENCHMAN OF MAINE	0.0188679	3.507821272591726
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	3.507821272591726
DIASTEMATOMYELIA	0.0188679	3.507821272591726
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	3.507821272591726
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	3.507821272591726
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	3.507821272591726
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	3.507821272591726
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	3.507821272591726
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	3.507821272591726
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	3.507821272591726
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	3.507821272591726
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	3.507821272591726
THUMBS, CONGENITAL CLASPED	0.0188679	3.507821272591726
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	3.507821272591726
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	3.507821272591726
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	3.507821272591726
SPASTIC PSEUDOSCLEROSIS	0.0188679	3.507821272591726
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	3.507821272591726
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	3.507821272591726
MYOPATHY, CONGENITAL	0.0188679	3.507821272591726
ALCOHOL DEPENDENCE	0.0188679	3.507821272591726
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	3.507821272591726
269800 SENILE PLAQUE FORMATION	0.0188679	3.507821272591726
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	3.507821272591726
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	3.507821272591726
PALMOMENTAL REFLEX	0.0188679	3.507821272591726
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	3.507821272591726
ANDROSTENONE, ABILITY TO SMELL	0.0188679	3.507821272591726
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	3.507821272591726
ENDOCARDIAL FIBROELASTOSIS	0.0188679	3.507821272591726
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	3.507821272591726
MOTION SICKNESS	0.0188679	3.507821272591726
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	3.507821272591726
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	3.507821272591726
AL KAISSI SYNDROME; ALKAS	0.018468932	3.4336472289788507
DESANTO-SHINAWI SYNDROME	0.018468932	3.4336472289788507
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.01835499	3.4124637283538926
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.01835499	3.4124637283538926
LOEYS-DIETZ SYNDROME 5	0.01816632	3.3773871888608973
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.01811011	3.3669369196877312
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.01811011	3.3669369196877312
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01811011	3.3669369196877312
SILVER-RUSSELL SYNDROME; SRS	0.018085282	3.3623210277996094
PALLISTER-HALL SYNDROME	0.018085282	3.3623210277996094
WEBB-DATTANI SYNDROME; WEDAS	0.018085282	3.3623210277996094
SEPTOOPTIC DYSPLASIA	0.018085282	3.3623210277996094
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.018085282	3.3623210277996094
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.018085282	3.3623210277996094
MICROPHTHALMIA, SYNDROMIC 1	0.018062790000000002	3.3581394328121896
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.018062790000000002	3.3581394328121896
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.017793082	3.307996732257906
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.017793082	3.307996732257906
MENTAL RETARDATION, X-LINKED 107; MRX107	0.017793082	3.307996732257906
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.017793082	3.307996732257906
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.017793082	3.307996732257906
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.017793082	3.307996732257906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.017793082	3.307996732257906
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.017793082	3.307996732257906
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.017793082	3.307996732257906
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.017793082	3.307996732257906
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01762505	3.2767571017703507
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0172414	3.2054309005911095
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0172414	3.2054309005911095
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0172414	3.2054309005911095
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0172414	3.2054309005911095
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0172414	3.2054309005911095
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0172414	3.2054309005911095
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.0172414	3.2054309005911095
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0172414	3.2054309005911095
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.0172414	3.2054309005911095
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.0172414	3.2054309005911095
RHYNS SYNDROME; RHYNS	0.0172414	3.2054309005911095
#245590 GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY;;LARON SYNDROME DUE TO POSTRECEPTOR DEFECT;;GROWTH HORMONE INSENSITIVITY DUE TO POSTRECEPTOR DEFECT	0.0172414	3.2054309005911095
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0172414	3.2054309005911095
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0172414	3.2054309005911095
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.0172414	3.2054309005911095
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0172414	3.2054309005911095
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0172414	3.2054309005911095
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.017108972	3.1808105795438926
PHELAN-MCDERMID SYNDROME; PHMDS	0.017108972	3.1808105795438926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.017108972	3.1808105795438926
HYPERTELORISM, TEEBI TYPE; TBHS	0.0169492	3.1511066050494065
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.0169492	3.1511066050494065
MENTAL RETARDATION, X-LINKED 82	0.0169492	3.1511066050494065
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.0169492	3.1511066050494065
46,XY SEX REVERSAL 9; SRXY9	0.0169492	3.1511066050494065
RETT SYNDROME; RTT	0.0169492	3.1511066050494065
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.0169492	3.1511066050494065
MOEBIUS SYNDROME; MBS	0.01690298	3.1425136244199146
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.016882872	3.1387752502421167
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.016882872	3.1387752502421167
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.01651146	3.069724274007567
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01651146	3.069724274007567
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.01651146	3.069724274007567
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.01651146	3.069724274007567
CYCLIC VOMITING SYNDROME	0.01626509	3.0239204523353926
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.01626509	3.0239204523353926
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.01626509	3.0239204523353926
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.01626509	3.0239204523353926
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.01603899	2.9818851230336163
JOHANSON-BLIZZARD SYNDROME; JBS	0.01603899	2.9818851230336163
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.01603899	2.9818851230336163
AUSTRALIA ANTIGEN	0.015995382	2.9737777517811095
Cerebral creatine deficiency syndrome 3	0.015995382	2.9737777517811095
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.015995382	2.9737777517811095
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.015995382	2.9737777517811095
MENTAL RETARDATION, X-LINKED 9	0.015995382	2.9737777517811095
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.015995382	2.9737777517811095
MENTAL RETARDATION, X-LINKED 88	0.015995382	2.9737777517811095
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.015995382	2.9737777517811095
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.015995382	2.9737777517811095
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.015954432	2.966164541984967
ANGELMAN SYNDROME	0.015954432	2.966164541984967
CHROMOSOME 1P36 DELETION SYNDROME	0.015954432	2.966164541984967
LYMPHEDEMA, HEREDITARY, III	0.015769282	2.9317424224793323
LIG4 SYNDROME	0.015769282	2.9317424224793323
TOWNES-BROCKS SYNDROME 1; TBS1	0.015769282	2.9317424224793323
DIGEORGE SYNDROME; DGS	0.015769282	2.9317424224793323
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.015769282	2.9317424224793323
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.015451481999999999	2.8726587088477333
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.015151499999999998	2.8168876245726095
Potocki-Lupski syndrome (17p11.2 duplication syndrome)	0.015151499999999998	2.8168876245726095
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.015151499999999998	2.8168876245726095
HYPERLEXIA	0.015151499999999998	2.8168876245726095
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.015151499999999998	2.8168876245726095
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.015151499999999998	2.8168876245726095
1q21.1 recurrent microduplication (possible susceptibility locus for neurodevelopmental disorders)	0.015151499999999998	2.8168876245726095
BRUNNER SYNDROME; BRNRS	0.015151499999999998	2.8168876245726095
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.015151499999999998	2.8168876245726095
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.015151499999999998	2.8168876245726095
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.015151499999999998	2.8168876245726095
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.015151499999999998	2.8168876245726095
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.015151499999999998	2.8168876245726095
AUTISM, SUSCEPTIBILITY TO, 18	0.015151499999999998	2.8168876245726095
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.015151499999999998	2.8168876245726095
FRAGILE X MENTAL RETARDATION SYNDROME	0.015151499999999998	2.8168876245726095
CHROMOSOME 17q12 DELETION SYNDROME	0.015151499999999998	2.8168876245726095
AUTISM	0.015151499999999998	2.8168876245726095
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.015151499999999998	2.8168876245726095
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.015151499999999998	2.8168876245726095
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.015151499999999998	2.8168876245726095
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.015151499999999998	2.8168876245726095
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.015151499999999998	2.8168876245726095
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.015151499999999998	2.8168876245726095
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.015151499999999998	2.8168876245726095
NANCE-HORAN SYNDROME	0.015151499999999998	2.8168876245726095
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.01511055	2.8092744147764677
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.014925399999999998	2.7748522952708328
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.014925399999999998	2.7748522952708328
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.014925399999999998	2.7748522952708328
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.014925399999999998	2.7748522952708328
PRECOCIOUS PUBERTY, CENTRAL	0.014925399999999998	2.7748522952708328
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.014925399999999998	2.7748522952708328
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.014925399999999998	2.7748522952708328
MYXEDEMA	0.014925399999999998	2.7748522952708328
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.014925399999999998	2.7748522952708328
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.014925399999999998	2.7748522952708328
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.014925399999999998	2.7748522952708328
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.014925399999999998	2.7748522952708328
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.014925399999999998	2.7748522952708328
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.014925399999999998	2.7748522952708328
COWDEN SYNDROME 6; CWS6	0.014925399999999998	2.7748522952708328
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.014925399999999998	2.7748522952708328
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.014925399999999998	2.7748522952708328
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.014925399999999998	2.7748522952708328
#612885 PREMATURE OVARIAN FAILURE 10; POF10MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3, INCLUDED;MENOQ3, INCLUDED	0.014925399999999998	2.7748522952708328
COWDEN SYNDROME 5; CWS5	0.014925399999999998	2.7748522952708328
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.014925399999999998	2.7748522952708328
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.014925399999999998	2.7748522952708328
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.014925399999999998	2.7748522952708328
CORNELIA DE LANGE SYNDROME 3	0.014840842	2.759131714222184
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.014607599999999998	2.715768581639234
WILSON DISEASE	0.014548310000000002	2.704745694977128
GAPO SYNDROME; GAPOS	0.014548310000000002	2.704745694977128
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.014337891999999998	2.66562588108495
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.014337891999999998	2.66562588108495
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.014337891999999998	2.66562588108495
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.01400704	2.6041156078865804
MARTSOLF SYNDROME	0.01399696	2.6022415870136837
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.013494009999999999	2.5087357538764503
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.013494009999999999	2.5087357538764503
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.013494009999999999	2.5087357538764503
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.013321072000000002	2.476584025531512
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.013321072000000002	2.476584025531512
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.013321072000000002	2.476584025531512
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.013321072000000002	2.476584025531512
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.013321072000000002	2.476584025531512
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.013321072000000002	2.476584025531512
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.013321072000000002	2.476584025531512
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.013321072000000002	2.476584025531512
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013321072000000002	2.476584025531512
ZTTK SYNDROME; ZTTKS	0.013321072000000002	2.476584025531512
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.013321072000000002	2.476584025531512
JABERI-ELAHI SYNDROME; JABELS	0.013321072000000002	2.476584025531512
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.013321072000000002	2.476584025531512
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.013321072000000002	2.476584025531512
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.01289345	2.3970827801237977
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.01289345	2.3970827801237977
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.01289345	2.3970827801237977
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01289345	2.3970827801237977
COCKAYNE SYNDROME A; CSA	0.01289345	2.3970827801237977
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.01247719	2.3196938983230124
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.01247719	2.3196938983230124
LATERAL MENINGOCELE SYNDROME	0.01247719	2.3196938983230124
NEMALINE MYOPATHY 7; NEM7	0.01247719	2.3196938983230124
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.01247719	2.3196938983230124
WARBURG MICRO SYNDROME 1	0.01247719	2.3196938983230124
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.01247719	2.3196938983230124
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.01247719	2.3196938983230124
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.01247719	2.3196938983230124
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.012336422000000001	2.2935230481011972
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.012336422000000001	2.2935230481011972
NIEMANN-PICK DISEASE, TYPE A	0.012336422000000001	2.2935230481011972
Glycosylphosphatidylinositol biosynthesis defect 18	0.012336422000000001	2.2935230481011972
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.012336422000000001	2.2935230481011972
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.012336422000000001	2.2935230481011972
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.012266771999999999	2.280574084430835
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.012266771999999999	2.280574084430835
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.012266771999999999	2.280574084430835
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.012266771999999999	2.280574084430835
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.012207482000000002	2.269551197768729
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.012207482000000002	2.269551197768729
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.012207482000000002	2.269551197768729
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.012207482000000002	2.269551197768729
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.012207482000000002	2.269551197768729
3MC SYNDROME 2	0.012207482000000002	2.269551197768729
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.012207482000000002	2.269551197768729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.012207482000000002	2.269551197768729
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.012207482000000002	2.269551197768729
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.012207482000000002	2.269551197768729
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.011944902	2.2207336976888503
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.011944902	2.2207336976888503
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.011666212	2.168921110678182
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.011666212	2.168921110678182
HEART AND BRAIN MALFORMATION SYNDROME	0.011666212	2.168921110678182
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.011666212	2.168921110678182
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.011666212	2.168921110678182
OROFACIODIGITAL SYNDROME XIV; OFD14	0.011666212	2.168921110678182
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.011666212	2.168921110678182
COFFIN-SIRIS SYNDROME 2; CSS2	0.011666212	2.168921110678182
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.011666212	2.168921110678182
CHROMOSOME 16Q22 DELETION SYNDROME	0.011666212	2.168921110678182
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.011666212	2.168921110678182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.011666212	2.168921110678182
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.01149254	2.1366329208926973
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.01149254	2.1366329208926973
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.011492539999999999	2.136632920892697
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.011492539999999999	2.136632920892697
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.011492539999999999	2.136632920892697
LIVER FAILURE, INFANTILE, TRANSIENT	0.011492539999999999	2.136632920892697
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.011492539999999999	2.136632920892697
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.011492539999999999	2.136632920892697
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.011422889999999998	2.1236839572223354
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.011422889999999998	2.1236839572223354
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.011422889999999998	2.1236839572223354
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.011363600000000001	2.1126610705602293
#278250 WRINKLY SKIN SYNDROME; WSS	0.011363600000000001	2.1126610705602293
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.011363600000000001	2.1126610705602293
ODONTOCHONDRODYSPLASIA; ODCD	0.011363600000000001	2.1126610705602293
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.011363600000000001	2.1126610705602293
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.011363600000000001	2.1126610705602293
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.011363600000000001	2.1126610705602293
MEESTER-LOEYS SYNDROME; MRLS	0.011363600000000001	2.1126610705602293
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.011363600000000001	2.1126610705602293
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.011363600000000001	2.1126610705602293
CRANIOFACIOFRONTODIGITAL SYNDROME	0.011363600000000001	2.1126610705602293
STICKLER SYNDROME, TYPE II	0.011363600000000001	2.1126610705602293
MACS SYNDROME	0.011363600000000001	2.1126610705602293
BAZEX SYNDROME; BZX	0.011363600000000001	2.1126610705602293
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.011363600000000001	2.1126610705602293
#608895 MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	0.011363600000000001	2.1126610705602293
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.011363600000000001	2.1126610705602293
OSTEOGENESIS IMPERFECTA, TYPE I	0.011363600000000001	2.1126610705602293
MARFANOID HYPERMOBILITY SYNDROME	0.011363600000000001	2.1126610705602293
MEIER-GORLIN SYNDROME 2; MGORS2	0.011363600000000001	2.1126610705602293
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.011363600000000001	2.1126610705602293
OSTEOGENESIS IMPERFECTA, TYPE V	0.011363600000000001	2.1126610705602293
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.011363600000000001	2.1126610705602293
VESICOURETERAL REFLUX 8; VUR8	0.011363600000000001	2.1126610705602293
BRITTLE CORNEA SYNDROME 2; BCS2	0.011363600000000001	2.1126610705602293
ARGININOSUCCINIC ACIDURIA	0.011222832	2.0864902203384132
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.011222832	2.0864902203384132
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.011222832	2.0864902203384132
PELGER-HUET ANOMALY; PHA	0.011153182	2.073541256668052
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.011153182	2.073541256668052
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.011153182	2.073541256668052
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.011153182	2.073541256668052
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.011153182	2.073541256668052
SAUL-WILSON SYNDROME; SWILS	0.011153182	2.073541256668052
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.01082233	2.0120309834696823
ACROCALLOSAL SYNDROME; ACLS	0.01082233	2.0120309834696823
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.01082233	2.0120309834696823
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.01082233	2.0120309834696823
GABRIELE-DE VRIES SYNDROME; GADEVS	0.010552622000000001	1.9618882829153985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.010552622000000001	1.9618882829153985
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.010552622000000001	1.9618882829153985
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010552622000000001	1.9618882829153985
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.010552622000000001	1.9618882829153985
MENTAL RETARDATION, X-LINKED 104; MRX104	0.010552622000000001	1.9618882829153985
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.010552622000000001	1.9618882829153985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.010552622000000001	1.9618882829153985
CATEL-MANZKE SYNDROME; CATMANS	0.010552622000000001	1.9618882829153985
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.01037895	1.9296000931299135
DIAMOND-BLACKFAN ANEMIA 8	0.010309299999999999	1.9166511294595518
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.010309299999999999	1.9166511294595518
IMMUNODEFICIENCY 46; IMD46	0.010309299999999999	1.9166511294595518
DIAMOND-BLACKFAN ANEMIA 4	0.010309299999999999	1.9166511294595518
#613501 AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79A DEFECT	0.010309299999999999	1.9166511294595518
HEMOCHROMATOSIS, TYPE 3; HFE3	0.010309299999999999	1.9166511294595518
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.010309299999999999	1.9166511294595518
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.010309299999999999	1.9166511294595518
THROMBOCYTOPENIA 5; THC5	0.010309299999999999	1.9166511294595518
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.010309299999999999	1.9166511294595518
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.010309299999999999	1.9166511294595518
#615214 AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO PIK3R1 DEFECT	0.010309299999999999	1.9166511294595518
BARE LYMPHOCYTE SYNDROME, TYPE II	0.010309299999999999	1.9166511294595518
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.010309299999999999	1.9166511294595518
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.010309299999999999	1.9166511294595518
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.010309299999999999	1.9166511294595518
GLUTATHIONE SYNTHETASE DEFICIENCY	0.010309299999999999	1.9166511294595518
FELTY SYNDROME	0.010309299999999999	1.9166511294595518
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.010309299999999999	1.9166511294595518
NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA	0.010309299999999999	1.9166511294595518
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.010309299999999999	1.9166511294595518
CYCLIC NEUTROPENIA	0.010309299999999999	1.9166511294595518
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.010309299999999999	1.9166511294595518
BARTH SYNDROME; BTHS	0.010309299999999999	1.9166511294595518
MYELOCEREBELLAR DISORDER	0.010309299999999999	1.9166511294595518
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.010309299999999999	1.9166511294595518
IMMUNODEFICIENCY 55; IMD55	0.010309299999999999	1.9166511294595518
#607847 NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS;;NONIMMUNE CHRONIC IDIOPATHIC NEUTROPENIA OF ADULTS;;NI-CINA	0.010309299999999999	1.9166511294595518
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.010309299999999999	1.9166511294595518
WHIM SYNDROME	0.010309299999999999	1.9166511294595518
THROMBOCYTOPENIA, CYCLIC	0.010309299999999999	1.9166511294595518
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.010309299999999999	1.9166511294595518
RETINAL VENOUS BEADING	0.010309299999999999	1.9166511294595518
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.010309299999999999	1.9166511294595518
FANCONI ANEMIA	0.010309299999999999	1.9166511294595518
#202700 NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1	0.010309299999999999	1.9166511294595518
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.010309299999999999	1.9166511294595518
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.010309299999999999	1.9166511294595518
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.010309299999999999	1.9166511294595518
IMMUNODEFICIENCY 50; IMD50	0.010309299999999999	1.9166511294595518
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.010309299999999999	1.9166511294595518
IMMUNODEFICIENCY 21; IMD21	0.010309299999999999	1.9166511294595518
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.010309299999999999	1.9166511294595518
#613107 NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2	0.010309299999999999	1.9166511294595518
DIAMOND-BLACKFAN ANEMIA 18; DBA18	0.010309299999999999	1.9166511294595518
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.010309299999999999	1.9166511294595518
#300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX;;XLN	0.010309299999999999	1.9166511294595518
LETTERER-SIWE DISEASE	0.010309299999999999	1.9166511294595518
LAZY LEUKOCYTE SYNDROME	0.010309299999999999	1.9166511294595518
#614868 T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITHOR WITHOUT CARDIAC MALFORMATIONS; TIIAC;;STK4 DEFICIENCY;;MST1 DEFICIENCY	0.010309299999999999	1.9166511294595518
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.010309299999999999	1.9166511294595518
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.00998743	1.8568107427175673
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00970874	1.8049981557068988
BARBER-SAY SYNDROME; BBRSAY	0.00970874	1.8049981557068988
HYDROLETHALUS SYNDROME 1	0.00970874	1.8049981557068988
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00970874	1.8049981557068988
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00970874	1.8049981557068988
KENNERKNECHT SYNDROME	0.00970874	1.8049981557068988
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00970874	1.8049981557068988
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.00970874	1.8049981557068988
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00970874	1.8049981557068988
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00970874	1.8049981557068988
FOCAL DERMAL HYPOPLASIA; FDH	0.00970874	1.8049981557068988
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00970874	1.8049981557068988
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00970874	1.8049981557068988
KEIPERT SYNDROME; KPTS	0.00970874	1.8049981557068988
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00970874	1.8049981557068988
MAXILLOFACIAL DYSOSTOSIS	0.00970874	1.8049981557068988
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00970874	1.8049981557068988
BRANCHIOOTIC SYNDROME 2	0.00970874	1.8049981557068988
NEU-LAXOVA SYNDROME 2; NLS2	0.00970874	1.8049981557068988
AASE-SMITH SYNDROME I	0.00970874	1.8049981557068988
3MC SYNDROME 3	0.00970874	1.8049981557068988
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00970874	1.8049981557068988
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00970874	1.8049981557068988
FIBROCHONDROGENESIS 1; FBCG1	0.00970874	1.8049981557068988
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00970874	1.8049981557068988
SIMOSA CRANIOFACIAL SYNDROME	0.00970874	1.8049981557068988
SECKEL SYNDROME 1; SCKL1	0.00970874	1.8049981557068988
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00970874	1.8049981557068988
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00970874	1.8049981557068988
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00970874	1.8049981557068988
VAN BOGAERT-HOZAY SYNDROME	0.00970874	1.8049981557068988
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00970874	1.8049981557068988
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00970874	1.8049981557068988
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00970874	1.8049981557068988
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00970874	1.8049981557068988
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.00970874	1.8049981557068988
184705 STEINFELD SYNDROME	0.00970874	1.8049981557068988
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00970874	1.8049981557068988
SHASHI-PENA SYNDROME; SHAPNS	0.009151712000000001	1.7014384236842988
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.009151712000000001	1.7014384236842988
PEHO SYNDROME; PEHO	0.009151712000000001	1.7014384236842988
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.009151712000000001	1.7014384236842988
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.009151712000000001	1.7014384236842988
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.009151712000000001	1.7014384236842988
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.009151712000000001	1.7014384236842988
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.009151712	1.7014384236842983
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.009151712	1.7014384236842983
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.009151712	1.7014384236842983
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.009151712	1.7014384236842983
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.009151712	1.7014384236842983
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.009151712	1.7014384236842983
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.008760192	1.6286490732719519
CRANIOSYNOSTOSIS 6; CRS6	0.008760192	1.6286490732719519
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.008760192	1.6286490732719519
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.008760192	1.6286490732719519
RECOMBINANT CHROMOSOME 8 SYNDROME	0.008760192	1.6286490732719519
CRANIOFRONTONASAL SYNDROME; CFNS	0.008760192	1.6286490732719519
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.008760192	1.6286490732719519
LARSEN-LIKE SYNDROME	0.008760192	1.6286490732719519
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.008760192	1.6286490732719519
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.008760192	1.6286490732719519
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.008760192	1.6286490732719519
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.008760192	1.6286490732719519
MAPLE SYRUP URINE DISEASE; MSUD	0.00830783	1.5445482964757986
LISSENCEPHALY, X-LINKED, 2	0.00830783	1.5445482964757986
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00830783	1.5445482964757986
DUBOWITZ SYNDROME	0.00830783	1.5445482964757986
NEMALINE MYOPATHY 4	0.00830783	1.5445482964757986
OHDO SYNDROME	0.00830783	1.5445482964757986
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00830783	1.5445482964757986
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00830783	1.5445482964757986
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00830783	1.5445482964757986
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00830783	1.5445482964757986
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.00830783	1.5445482964757986
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00830783	1.5445482964757986
MYOTONIC DYSTROPHY 1	0.00830783	1.5445482964757986
PETERS-PLUS SYNDROME; PTRPLS	0.008038122	1.494405595921515
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.008038122	1.494405595921515
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.008038122	1.494405595921515
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.008038122	1.494405595921515
CHROMOSOME 16p13.3 DELETION SYNDROME	0.008038122	1.494405595921515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.008038122	1.494405595921515
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.008038122	1.494405595921515
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.008038122	1.494405595921515
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.008038122	1.494405595921515
AICARDI-GOUTIERES SYNDROME 5	0.008038122	1.494405595921515
JOUBERT SYNDROME 10	0.008038122	1.494405595921515
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.008038122	1.494405595921515
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.008038122	1.494405595921515
ZUNICH NEUROECTODERMAL SYNDROME	0.00791631	1.471758946063452
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00791631	1.471758946063452
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.00791631	1.471758946063452
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00791631	1.471758946063452
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00791631	1.471758946063452
MENTAL RETARDATION, X-LINKED 1	0.00791631	1.471758946063452
MENKES DISEASE	0.00791631	1.471758946063452
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00791631	1.471758946063452
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00791631	1.471758946063452
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00791631	1.471758946063452
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00791631	1.471758946063452
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00791631	1.471758946063452
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.00791631	1.471758946063452
SWEENEY-COX SYNDROME; SWCOS	0.007646602	1.4216162455091683
CDAGS SYNDROME	0.007646602	1.4216162455091683
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.007646602	1.4216162455091683
Muenke syndrome	0.007646602	1.4216162455091683
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.007646602	1.4216162455091683
ELSAHY-WATERS SYNDROME; ESWS	0.007646602	1.4216162455091683
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.007646602	1.4216162455091683
EVEN-PLUS SYNDROME	0.007646602	1.4216162455091683
BARDET-BIEDL SYNDROME 8; BBS8	0.007646602	1.4216162455091683
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007646602	1.4216162455091683
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.007646602	1.4216162455091683
611961 STEVENSON-CAREY SYNDROME	0.007646602	1.4216162455091683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.007646602	1.4216162455091683
CREE MENTAL RETARDATION SYNDROME	0.007646602	1.4216162455091683
#614976 CARPENTER SYNDROME 2; CRPT2	0.007646602	1.4216162455091683
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.007646602	1.4216162455091683
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00719424	1.3375154687130153
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00719424	1.3375154687130153
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00719424	1.3375154687130153
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00719424	1.3375154687130153
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.00719424	1.3375154687130153
NEMALINE MYOPATHY 3; NEM3	0.00719424	1.3375154687130153
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.00719424	1.3375154687130153
HYPOADRENOCORTICISM, FAMILIAL	0.00719424	1.3375154687130153
Ullrich congenital muscular dystrophy 1	0.00719424	1.3375154687130153
HYPOGLOSSIA WITH SITUS INVERSUS	0.00719424	1.3375154687130153
17q21.31 recurrent microdeletion syndrome	0.00719424	1.3375154687130153
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.00719424	1.3375154687130153
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00719424	1.3375154687130153
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00719424	1.3375154687130153
%608572 BURN-MCKEOWN SYNDROME	0.00719424	1.3375154687130153
MEIER-GORLIN SYNDROME 1; MGORS1	0.00719424	1.3375154687130153
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00719424	1.3375154687130153
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00719424	1.3375154687130153
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00719424	1.3375154687130153
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00719424	1.3375154687130153
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00719424	1.3375154687130153
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00719424	1.3375154687130153
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00719424	1.3375154687130153
PIERRE ROBIN SYNDROME	0.00719424	1.3375154687130153
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00719424	1.3375154687130153
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.00719424	1.3375154687130153
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00719424	1.3375154687130153
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00719424	1.3375154687130153
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00719424	1.3375154687130153
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00719424	1.3375154687130153
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.00719424	1.3375154687130153
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00719424	1.3375154687130153
16p11.2-p12.2 microdeletion syndrome	0.00719424	1.3375154687130153
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00719424	1.3375154687130153
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.00719424	1.3375154687130153
2p15-16.1 microdeletion syndrome	0.00719424	1.3375154687130153
HAMAMY SYNDROME; HMMS	0.00680272	1.2647261183006688
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00680272	1.2647261183006688
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00680272	1.2647261183006688
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00680272	1.2647261183006688
Contractural arachnodactyly, congenital	0.00680272	1.2647261183006688
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.00680272	1.2647261183006688
CEREBROOCULONASAL SYNDROME	0.00680272	1.2647261183006688
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.00680272	1.2647261183006688
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00680272	1.2647261183006688
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00680272	1.2647261183006688
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00680272	1.2647261183006688
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.00680272	1.2647261183006688
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00680272	1.2647261183006688
#614416 RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES;RHFCA	0.00680272	1.2647261183006688
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00680272	1.2647261183006688
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00680272	1.2647261183006688
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00680272	1.2647261183006688
AYME-GRIPP SYNDROME; AYGRP	0.00680272	1.2647261183006688
PSEUDODIASTROPHIC DYSPLASIA	0.00680272	1.2647261183006688
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00680272	1.2647261183006688
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00680272	1.2647261183006688
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00680272	1.2647261183006688
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00680272	1.2647261183006688
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00680272	1.2647261183006688
WARBURG MICRO SYNDROME 3; WARBM3	0.00680272	1.2647261183006688
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00680272	1.2647261183006688
WARBURG MICRO SYNDROME 2; WARBM2	0.00680272	1.2647261183006688
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00680272	1.2647261183006688
POTOCKI-SHAFFER SYNDROME	0.00680272	1.2647261183006688
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00680272	1.2647261183006688
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00680272	1.2647261183006688
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00680272	1.2647261183006688
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00680272	1.2647261183006688
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00680272	1.2647261183006688
HUNTER-MACDONALD SYNDROME	0.00680272	1.2647261183006688
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00680272	1.2647261183006688
ACHARD SYNDROME	0.00680272	1.2647261183006688
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00680272	1.2647261183006688
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00680272	1.2647261183006688
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00680272	1.2647261183006688
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00680272	1.2647261183006688
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00680272	1.2647261183006688
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00680272	1.2647261183006688
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00680272	1.2647261183006688
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00680272	1.2647261183006688
ROBERTS SYNDROME; RBS	0.00680272	1.2647261183006688
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00680272	1.2647261183006688
RENPENNING SYNDROME 1; RENS1	0.00680272	1.2647261183006688
CROUZON SYNDROME	0.00680272	1.2647261183006688
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00680272	1.2647261183006688
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005142182	0.9560075793881816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.005142182	0.9560075793881816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.005142182	0.9560075793881816
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.005142182	0.9560075793881816
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.005142182	0.9560075793881816
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.005142182	0.9560075793881816
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.005142182	0.9560075793881816
PEROXISOME BIOGENESIS DISORDER 3B	0.005142182	0.9560075793881816
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.005142182	0.9560075793881816
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.005142182	0.9560075793881816
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.005142182	0.9560075793881816
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.005142182	0.9560075793881816
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.005142182	0.9560075793881816
INFANTILE LIVER FAILURE SYNDROME 1	0.005142182	0.9560075793881816
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.005142182	0.9560075793881816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.005142182	0.9560075793881816
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.005142182	0.9560075793881816
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.005142182	0.9560075793881816
NIEMANN-PICK DISEASE, TYPE C2	0.005142182	0.9560075793881816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.005142182	0.9560075793881816
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.005142182	0.9560075793881816
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005142182	0.9560075793881816
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.005142182	0.9560075793881816
C SYNDROME	0.005142182	0.9560075793881816
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.005142182	0.9560075793881816
COACH SYNDROME	0.005142182	0.9560075793881816
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.005142182	0.9560075793881816
ARIMA SYNDROME	0.005142182	0.9560075793881816
GALACTOSE EPIMERASE DEFICIENCY	0.005142182	0.9560075793881816
PYRUVATE CARBOXYLASE DEFICIENCY	0.005142182	0.9560075793881816
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0042983	0.7991174521796818
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0042983	0.7991174521796818
GLYCOGEN STORAGE DISEASE II	0.0042983	0.7991174521796818
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0042983	0.7991174521796818
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.0042983	0.7991174521796818
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0042983	0.7991174521796818
COMBINED SAPOSIN DEFICIENCY	0.0042983	0.7991174521796818
GLYCOGEN STORAGE DISEASE IXC	0.0042983	0.7991174521796818
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0042983	0.7991174521796818
NEURAMINIDASE DEFICIENCY	0.0042983	0.7991174521796818
GLYCOGEN STORAGE DISEASE IXB	0.0042983	0.7991174521796818
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0042983	0.7991174521796818
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0042983	0.7991174521796818
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0042983	0.7991174521796818
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0042983	0.7991174521796818
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0042983	0.7991174521796818
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0042983	0.7991174521796818
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.0042983	0.7991174521796818
GLUTARIC ACIDEMIA I; GA1	0.0042983	0.7991174521796818
PSEUDO-TORCH SYNDROME 2	0.0042983	0.7991174521796818
ZIMMERMANN-LABAND SYNDROME 1	0.0042983	0.7991174521796818
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.0042983	0.7991174521796818
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0042983	0.7991174521796818
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0042983	0.7991174521796818
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0042983	0.7991174521796818
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.004028592	0.7489747516253981
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.004028592	0.7489747516253981
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004028592	0.7489747516253981
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.004028592	0.7489747516253981
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.004028592	0.7489747516253981
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004028592	0.7489747516253981
CITRULLINEMIA, CLASSIC	0.004028592	0.7489747516253981
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.004028592	0.7489747516253981
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.004028592	0.7489747516253981
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004028592	0.7489747516253981
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.004028592	0.7489747516253981
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.004028592	0.7489747516253981
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.004028592	0.7489747516253981
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.004028592	0.7489747516253981
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.004028592	0.7489747516253981
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.004028592	0.7489747516253981
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.004028592	0.7489747516253981
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004028592	0.7489747516253981
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.004028592	0.7489747516253981
HURLER SYNDROME	0.004028592	0.7489747516253981
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.004028592	0.7489747516253981
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.004028592	0.7489747516253981
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.00318471	0.5920846244168984
#615238 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS	0.00318471	0.5920846244168984
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00318471	0.5920846244168984
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00318471	0.5920846244168984
PORTAL HYPERTENSION, NONCIRRHOTIC	0.00318471	0.5920846244168984
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.00318471	0.5920846244168984
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00318471	0.5920846244168984
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.00318471	0.5920846244168984
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00318471	0.5920846244168984
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00318471	0.5920846244168984
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00318471	0.5920846244168984
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00318471	0.5920846244168984
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00318471	0.5920846244168984
BECKWITH-WIEDEMANN SYNDROME	0.00318471	0.5920846244168984
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00318471	0.5920846244168984
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00318471	0.5920846244168984
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00318471	0.5920846244168984
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00318471	0.5920846244168984
NIEMANN-PICK DISEASE, TYPE B	0.00318471	0.5920846244168984
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00318471	0.5920846244168984
GALACTOSEMIA	0.00318471	0.5920846244168984
APOLIPOPROTEIN C-II DEFICIENCY	0.00318471	0.5920846244168984
Lipodystrophy, congenital generalized, type 1	0.00318471	0.5920846244168984
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00318471	0.5920846244168984
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00318471	0.5920846244168984
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.00318471	0.5920846244168984
TRICHOHEPATOENTERIC SYNDROME 2	0.00318471	0.5920846244168984
REYNOLDS SYNDROME	0.00318471	0.5920846244168984
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.00318471	0.5920846244168984
GAUCHER DISEASE, TYPE IIIC	0.00318471	0.5920846244168984
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00318471	0.5920846244168984
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00318471	0.5920846244168984
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00318471	0.5920846244168984
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00318471	0.5920846244168984
SCLEROSING CHOLANGITIS, NEONATAL	0.00318471	0.5920846244168984
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00318471	0.5920846244168984
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00318471	0.5920846244168984
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.00318471	0.5920846244168984
CRANIOECTODERMAL DYSPLASIA 1	0.00318471	0.5920846244168984
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00318471	0.5920846244168984
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.00318471	0.5920846244168984
HEMOCHROMATOSIS, TYPE 2A	0.00318471	0.5920846244168984
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00318471	0.5920846244168984
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.00318471	0.5920846244168984
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00318471	0.5920846244168984
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00318471	0.5920846244168984
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00318471	0.5920846244168984
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00318471	0.5920846244168984
GAUCHER DISEASE, TYPE I	0.00318471	0.5920846244168984
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.00318471	0.5920846244168984
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00318471	0.5920846244168984
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00318471	0.5920846244168984
RETINITIS PIGMENTOSA 59; RP59	0.00318471	0.5920846244168984
POLYCYSTIC LIVER DISEASE 2	0.00318471	0.5920846244168984
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00318471	0.5920846244168984
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.00318471	0.5920846244168984
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00318471	0.5920846244168984
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.00318471	0.5920846244168984
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00318471	0.5920846244168984
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00318471	0.5920846244168984
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00318471	0.5920846244168984
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00318471	0.5920846244168984
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.00318471	0.5920846244168984
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.00318471	0.5920846244168984
HEMOCHROMATOSIS, TYPE 1	0.00318471	0.5920846244168984
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.00318471	0.5920846244168984
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00318471	0.5920846244168984
NEPHRONOPHTHISIS 19; NPHP19	0.00318471	0.5920846244168984
SICKLE CELL ANEMIA	0.00318471	0.5920846244168984
MORQUIO SYNDROME A	0.00318471	0.5920846244168984
#614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D	0.00318471	0.5920846244168984
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00318471	0.5920846244168984
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.00318471	0.5920846244168984
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00318471	0.5920846244168984
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00318471	0.5920846244168984
CAROLI DISEASE, ISOLATED	0.00318471	0.5920846244168984
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00318471	0.5920846244168984
HEMOCHROMATOSIS, TYPE 2B	0.00318471	0.5920846244168984
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.00318471	0.5920846244168984
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00318471	0.5920846244168984
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00318471	0.5920846244168984
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00318471	0.5920846244168984
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.00318471	0.5920846244168984
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00318471	0.5920846244168984
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.00318471	0.5920846244168984
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00318471	0.5920846244168984
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00318471	0.5920846244168984
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00318471	0.5920846244168984
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00318471	0.5920846244168984
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00318471	0.5920846244168984
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.00318471	0.5920846244168984
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00318471	0.5920846244168984
CHANARIN-DORFMAN SYNDROME	0.00318471	0.5920846244168984
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00318471	0.5920846244168984
HYPERLIPOPROTEINEMIA, TYPE ID	0.00318471	0.5920846244168984
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.00318471	0.5920846244168984
HARDIKAR SYNDROME	0.00318471	0.5920846244168984
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00318471	0.5920846244168984
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00318471	0.5920846244168984
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00318471	0.5920846244168984
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00318471	0.5920846244168984
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00318471	0.5920846244168984
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00318471	0.5920846244168984
TYROSINEMIA, TYPE I; TYRSN1	0.00318471	0.5920846244168984
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.00318471	0.5920846244168984
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00318471	0.5920846244168984
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.00318471	0.5920846244168984
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00318471	0.5920846244168984
HURLER-SCHEIE SYNDROME	0.00318471	0.5920846244168984
Lipodystrophy, congenital generalized, type 2	0.00318471	0.5920846244168984
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00318471	0.5920846244168984
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00318471	0.5920846244168984
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.00318471	0.5920846244168984
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.00318471	0.5920846244168984
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00318471	0.5920846244168984
TANGIER DISEASE; TGD	0.00318471	0.5920846244168984
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00318471	0.5920846244168984
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00318471	0.5920846244168984
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00318471	0.5920846244168984
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.00318471	0.5920846244168984
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00318471	0.5920846244168984
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00318471	0.5920846244168984
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00318471	0.5920846244168984
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00318471	0.5920846244168984
#613977 CYANOSIS, TRANSIENT NEONATAL; TNCY	0.00318471	0.5920846244168984
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.00318471	0.5920846244168984
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00318471	0.5920846244168984
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00318471	0.5920846244168984
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00318471	0.5920846244168984
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001957472	0.3639229549712831
OROFACIODIGITAL SYNDROME VI	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001957472	0.3639229549712831
JOUBERT SYNDROME 1	0.001957472	0.3639229549712831
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001957472	0.3639229549712831
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001957472	0.3639229549712831
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.001957472	0.3639229549712831
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001957472	0.3639229549712831
SALLA DISEASE	0.001957472	0.3639229549712831
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001957472	0.3639229549712831
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001957472	0.3639229549712831
MEVALONIC ACIDURIA; MEVA	0.001957472	0.3639229549712831
PEROXISOME BIOGENESIS DISORDER 5B	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001957472	0.3639229549712831
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001957472	0.3639229549712831
HAREL-YOON SYNDROME; HAYOS	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001957472	0.3639229549712831
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001957472	0.3639229549712831
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001957472	0.3639229549712831
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001957472	0.3639229549712831
JOUBERT SYNDROME 8	0.001957472	0.3639229549712831
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001957472	0.3639229549712831
MENTAL RETARDATION, X-LINKED 99	0.001957472	0.3639229549712831
HOLOPROSENCEPHALY 2; HPE2	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001957472	0.3639229549712831
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001957472	0.3639229549712831
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001957472	0.3639229549712831
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001957472	0.3639229549712831
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001957472	0.3639229549712831
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.001957472	0.3639229549712831
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001957472	0.3639229549712831
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001957472	0.3639229549712831
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001957472	0.3639229549712831
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001957472	0.3639229549712831
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.001957472	0.3639229549712831
SCHINDLER DISEASE, TYPE I	0.001957472	0.3639229549712831
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001957472	0.3639229549712831
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001957472	0.3639229549712831
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001957472	0.3639229549712831
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.001957472	0.3639229549712831
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001957472	0.3639229549712831
KETOADIPICACIDURIA	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001957472	0.3639229549712831
JOUBERT SYNDROME 14	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001957472	0.3639229549712831
OPTIC ATROPHY 11; OPA11	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001957472	0.3639229549712831
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001957472	0.3639229549712831
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001957472	0.3639229549712831
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001957472	0.3639229549712831
MICROPHTHALMIA, SYNDROMIC 3	0.001957472	0.3639229549712831
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001957472	0.3639229549712831
LAMB-SHAFFER SYNDROME	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001957472	0.3639229549712831
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001957472	0.3639229549712831
XIA-GIBBS SYNDROME	0.001957472	0.3639229549712831
MARINESCO-SJOGREN SYNDROME; MSS	0.001957472	0.3639229549712831
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001957472	0.3639229549712831
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001957472	0.3639229549712831
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001957472	0.3639229549712831
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001957472	0.3639229549712831
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001957472	0.3639229549712831
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001957472	0.3639229549712831
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.001957472	0.3639229549712831
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001957472	0.3639229549712831
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001957472	0.3639229549712831
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001957472	0.3639229549712831
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001957472	0.3639229549712831
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001957472	0.3639229549712831
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001957472	0.3639229549712831
JOUBERT SYNDROME 6	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001957472	0.3639229549712831
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001957472	0.3639229549712831
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001957472	0.3639229549712831
ADAMS-OLIVER SYNDROME 1; AOS1	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.001957472	0.3639229549712831
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001957472	0.3639229549712831
JOUBERT SYNDROME 27	0.001957472	0.3639229549712831
JOUBERT SYNDROME 32; JBTS32	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001957472	0.3639229549712831
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001957472	0.3639229549712831
NOONAN SYNDROME 6; NS6	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.001957472	0.3639229549712831
EMANUEL SYNDROME	0.001957472	0.3639229549712831
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001957472	0.3639229549712831
CHROMOSOME 10Q26 DELETION SYNDROME	0.001957472	0.3639229549712831
GENITOPATELLAR SYNDROME; GTPTS	0.001957472	0.3639229549712831
FUMARASE DEFICIENCY; FMRD	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001957472	0.3639229549712831
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001957472	0.3639229549712831
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001957472	0.3639229549712831
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001957472	0.3639229549712831
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001957472	0.3639229549712831
JOUBERT SYNDROME 28	0.001957472	0.3639229549712831
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001957472	0.3639229549712831
JOUBERT SYNDROME 2	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001957472	0.3639229549712831
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.001957472	0.3639229549712831
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001957472	0.3639229549712831
JOUBERT SYNDROME 25	0.001957472	0.3639229549712831
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.001957472	0.3639229549712831
CHROMOSOME 5Q12 DELETION SYNDROME	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001957472	0.3639229549712831
DIAPHANOSPONDYLODYSOSTOSIS	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001957472	0.3639229549712831
COHEN-GIBSON SYNDROME; COGIS	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001957472	0.3639229549712831
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001957472	0.3639229549712831
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001957472	0.3639229549712831
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001957472	0.3639229549712831
BOHRING-OPITZ SYNDROME	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001957472	0.3639229549712831
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001957472	0.3639229549712831
GRISCELLI SYNDROME, TYPE 1	0.001957472	0.3639229549712831
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.001957472	0.3639229549712831
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001957472	0.3639229549712831
MENTAL RETARDATION, X-LINKED 41	0.001957472	0.3639229549712831
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001957472	0.3639229549712831
COFFIN-SIRIS SYNDROME 7; CSS7	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001957472	0.3639229549712831
MUCOLIPIDOSIS IV; ML4	0.001957472	0.3639229549712831
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001957472	0.3639229549712831
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001957472	0.3639229549712831
CHROMOSOME 4q21 DELETION SYNDROME	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001957472	0.3639229549712831
CODAS SYNDROME	0.001957472	0.3639229549712831
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001957472	0.3639229549712831
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.001957472	0.3639229549712831
MEND SYNDROME; MEND	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001957472	0.3639229549712831
AU-KLINE SYNDROME; AUKS	0.001957472	0.3639229549712831
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001957472	0.3639229549712831
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001957472	0.3639229549712831
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.001957472	0.3639229549712831
YOU-HOOVER-FONG SYNDROME; YHFS	0.001957472	0.3639229549712831
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.001957472	0.3639229549712831
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.001957472	0.3639229549712831
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001957472	0.3639229549712831
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001957472	0.3639229549712831
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001957472	0.3639229549712831
Pontine tegmental cap dysplasia	0.001957472	0.3639229549712831
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.001957472	0.3639229549712831
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001957472	0.3639229549712831
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001957472	0.3639229549712831
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001957472	0.3639229549712831
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001957472	0.3639229549712831
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001957472	0.3639229549712831
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001957472	0.3639229549712831
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.001957472	0.3639229549712831
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.001957472	0.3639229549712831
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001957472	0.3639229549712831
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001957472	0.3639229549712831
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001957472	0.3639229549712831
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001957472	0.3639229549712831
PEROXISOME BIOGENESIS DISORDER 6B	0.001957472	0.3639229549712831
HADZISELIMOVIC SYNDROME	0.001957472	0.3639229549712831
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001957472	0.3639229549712831
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.001957472	0.3639229549712831
JOUBERT SYNDROME 15	0.001957472	0.3639229549712831
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001957472	0.3639229549712831
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001957472	0.3639229549712831
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001957472	0.3639229549712831
IMMUNODEFICIENCY 49; IMD49	0.001957472	0.3639229549712831
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001957472	0.3639229549712831
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001957472	0.3639229549712831
HOLOPROSENCEPHALY 1; HPE1	0.001957472	0.3639229549712831
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001957472	0.3639229549712831
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001957472	0.3639229549712831
VICI SYNDROME; VICIS	0.001957472	0.3639229549712831
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.001957472	0.3639229549712831
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001957472	0.3639229549712831
PETTIGREW SYNDROME	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001957472	0.3639229549712831
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001957472	0.3639229549712831
WARSAW BREAKAGE SYNDROME; WABS	0.001957472	0.3639229549712831
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001957472	0.3639229549712831
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001957472	0.3639229549712831
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001957472	0.3639229549712831
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.001957472	0.3639229549712831
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001957472	0.3639229549712831
GOLDBERG-SHPRINTZEN SYNDROME	0.001957472	0.3639229549712831
LEIGH SYNDROME; LS	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001957472	0.3639229549712831
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.001957472	0.3639229549712831
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001957472	0.3639229549712831
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001957472	0.3639229549712831
JOUBERT SYNDROME 7	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001957472	0.3639229549712831
JOUBERT SYNDROME 31; JBTS31	0.001957472	0.3639229549712831
PEROXISOME BIOGENESIS DISORDER 10B	0.001957472	0.3639229549712831
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001957472	0.3639229549712831
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001957472	0.3639229549712831
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001957472	0.3639229549712831
JOUBERT SYNDROME 21	0.001957472	0.3639229549712831
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001957472	0.3639229549712831
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001957472	0.3639229549712831
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.001957472	0.3639229549712831
XQ25 DUPLICATION SYNDROME	0.001957472	0.3639229549712831
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001957472	0.3639229549712831
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.001957472	0.3639229549712831
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001957472	0.3639229549712831
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001957472	0.3639229549712831
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001957472	0.3639229549712831
SULFOCYSTEINURIA	0.001957472	0.3639229549712831
RING CHROMOSOME 14 SYNDROME	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.001957472	0.3639229549712831
COFFIN-SIRIS SYNDROME 3; CSS3	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.001957472	0.3639229549712831
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001957472	0.3639229549712831
PELIZAEUS-MERZBACHER DISEASE	0.001957472	0.3639229549712831
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001957472	0.3639229549712831
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001957472	0.3639229549712831
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001957472	0.3639229549712831
JOUBERT SYNDROME 35; JBTS35	0.001957472	0.3639229549712831
AL-RAQAD SYNDROME; ARS	0.001957472	0.3639229549712831
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001957472	0.3639229549712831
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.001957472	0.3639229549712831
OROFACIODIGITAL SYNDROME XVI; OFD16	0.001957472	0.3639229549712831
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001957472	0.3639229549712831
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.001957472	0.3639229549712831
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001957472	0.3639229549712831
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.001957472	0.3639229549712831
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001957472	0.3639229549712831
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001957472	0.3639229549712831
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001957472	0.3639229549712831
COFFIN-SIRIS SYNDROME 4; CSS4	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001957472	0.3639229549712831
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.001957472	0.3639229549712831
NOONAN SYNDROME 11; NS11	0.001957472	0.3639229549712831
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001957472	0.3639229549712831
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.001957472	0.3639229549712831
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001957472	0.3639229549712831
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001957472	0.3639229549712831
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001957472	0.3639229549712831
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.001957472	0.3639229549712831
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.001957472	0.3639229549712831
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001957472	0.3639229549712831
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001957472	0.3639229549712831
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001957472	0.3639229549712831
ELEJALDE DISEASE	0.001957472	0.3639229549712831
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001957472	0.3639229549712831
WIEACKER-WOLFF SYNDROME	0.001957472	0.3639229549712831
TEMTAMY SYNDROME; TEMTYS	0.001957472	0.3639229549712831
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.001957472	0.3639229549712831
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001957472	0.3639229549712831
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001957472	0.3639229549712831
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001957472	0.3639229549712831
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001957472	0.3639229549712831
JOUBERT SYNDROME 24	0.001957472	0.3639229549712831
TARP SYNDROME; TARPS	0.001957472	0.3639229549712831
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.001957472	0.3639229549712831
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001957472	0.3639229549712831
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001957472	0.3639229549712831
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00111359	0.20703282776278337
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00111359	0.20703282776278337
SCHOLTE SYNDROME; SHLTS	0.00111359	0.20703282776278337
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00111359	0.20703282776278337
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00111359	0.20703282776278337
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00111359	0.20703282776278337
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00111359	0.20703282776278337
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00111359	0.20703282776278337
VISCERAL STEATOSIS, CONGENITAL	0.00111359	0.20703282776278337
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00111359	0.20703282776278337
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00111359	0.20703282776278337
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00111359	0.20703282776278337
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00111359	0.20703282776278337
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00111359	0.20703282776278337
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00111359	0.20703282776278337
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.00111359	0.20703282776278337
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00111359	0.20703282776278337
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00111359	0.20703282776278337
OPSISMODYSPLASIA; OPSMD	0.00111359	0.20703282776278337
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00111359	0.20703282776278337
PITT-HOPKINS SYNDROME	0.00111359	0.20703282776278337
LISSENCEPHALY 5; LIS5	0.00111359	0.20703282776278337
TAY-SACHS DISEASE; TSD	0.00111359	0.20703282776278337
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00111359	0.20703282776278337
ETHANOLAMINOSIS	0.00111359	0.20703282776278337
LISSENCEPHALY 3; LIS3	0.00111359	0.20703282776278337
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00111359	0.20703282776278337
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00111359	0.20703282776278337
VERVERI-BRADY SYNDROME; VERBRAS	0.00111359	0.20703282776278337
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00111359	0.20703282776278337
METACHROMATIC LEUKODYSTROPHY	0.00111359	0.20703282776278337
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00111359	0.20703282776278337
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00111359	0.20703282776278337
MARDEN-WALKER SYNDROME	0.00111359	0.20703282776278337
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00111359	0.20703282776278337
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00111359	0.20703282776278337
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00111359	0.20703282776278337
CEREBELLAR HYPOPLASIA	0.00111359	0.20703282776278337
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00111359	0.20703282776278337
JOUBERT SYNDROME 5	0.00111359	0.20703282776278337
PALLISTER-KILLIAN SYNDROME	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.00111359	0.20703282776278337
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00111359	0.20703282776278337
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00111359	0.20703282776278337
JOUBERT SYNDROME 3; JBTS3	0.00111359	0.20703282776278337
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00111359	0.20703282776278337
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00111359	0.20703282776278337
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00111359	0.20703282776278337
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00111359	0.20703282776278337
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00111359	0.20703282776278337
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00111359	0.20703282776278337
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00111359	0.20703282776278337
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00111359	0.20703282776278337
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00111359	0.20703282776278337
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00111359	0.20703282776278337
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00111359	0.20703282776278337
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00111359	0.20703282776278337
SMITH-KINGSMORE SYNDROME; SKS	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00111359	0.20703282776278337
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00111359	0.20703282776278337
ACID PHOSPHATASE DEFICIENCY	0.00111359	0.20703282776278337
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00111359	0.20703282776278337
SHPRINTZEN OMPHALOCELE SYNDROME	0.00111359	0.20703282776278337
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00111359	0.20703282776278337
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00111359	0.20703282776278337
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00111359	0.20703282776278337
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00111359	0.20703282776278337
SPINOCEREBELLAR ATAXIA 13	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00111359	0.20703282776278337
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00111359	0.20703282776278337
GLYCOGEN STORAGE DISEASE IV	0.00111359	0.20703282776278337
BETHLEM MYOPATHY 2; BTHLM2	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.00111359	0.20703282776278337
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00111359	0.20703282776278337
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00111359	0.20703282776278337
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00111359	0.20703282776278337
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00111359	0.20703282776278337
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.00111359	0.20703282776278337
COFFIN-SIRIS SYNDROME 8; CSS8	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.00111359	0.20703282776278337
MENTAL RETARDATION, X-LINKED 93	0.00111359	0.20703282776278337
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00111359	0.20703282776278337
Mulchandani-Bhoj-Conlin syndrome	0.00111359	0.20703282776278337
MOWAT-WILSON SYNDROME; MOWS	0.00111359	0.20703282776278337
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00111359	0.20703282776278337
DESBUQUOIS DYSPLASIA 1	0.00111359	0.20703282776278337
SUDDEN CARDIAC FAILURE, INFANTILE	0.00111359	0.20703282776278337
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00111359	0.20703282776278337
SPINOCEREBELLAR ATAXIA 1	0.00111359	0.20703282776278337
MENTAL RETARDATION, X-LINKED 102	0.00111359	0.20703282776278337
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00111359	0.20703282776278337
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00111359	0.20703282776278337
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00111359	0.20703282776278337
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00111359	0.20703282776278337
JOUBERT SYNDROME 4	0.00111359	0.20703282776278337
ARTERIAL TORTUOSITY SYNDROME	0.00111359	0.20703282776278337
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00111359	0.20703282776278337
EPILEPSY, HOT WATER, 1	0.00111359	0.20703282776278337
LESCH-NYHAN SYNDROME; LNS	0.00111359	0.20703282776278337
HYPERCALCEMIA, INFANTILE, 1	0.00111359	0.20703282776278337
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00111359	0.20703282776278337
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00111359	0.20703282776278337
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00111359	0.20703282776278337
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00111359	0.20703282776278337
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00111359	0.20703282776278337
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00111359	0.20703282776278337
GLYCINE ENCEPHALOPATHY; GCE	0.00111359	0.20703282776278337
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00111359	0.20703282776278337
CAMPOMELIC DYSPLASIA	0.00111359	0.20703282776278337
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00111359	0.20703282776278337
MENTAL RETARDATION, X-LINKED 19	0.00111359	0.20703282776278337
HYPOPHOSPHATASIA, INFANTILE	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00111359	0.20703282776278337
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00111359	0.20703282776278337
COFFIN-SIRIS SYNDROME 10; CSS10	0.00111359	0.20703282776278337
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00111359	0.20703282776278337
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00111359	0.20703282776278337
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00111359	0.20703282776278337
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00111359	0.20703282776278337
PORPHYRIA, ACUTE HEPATIC	0.00111359	0.20703282776278337
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00111359	0.20703282776278337
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00111359	0.20703282776278337
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00111359	0.20703282776278337
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00111359	0.20703282776278337
COFFIN-LOWRY SYNDROME; CLS	0.00111359	0.20703282776278337
STUVE-WIEDEMANN SYNDROME	0.00111359	0.20703282776278337
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00111359	0.20703282776278337
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00111359	0.20703282776278337
OSTEOGENESIS IMPERFECTA, TYPE X	0.00111359	0.20703282776278337
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00111359	0.20703282776278337
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00111359	0.20703282776278337
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00111359	0.20703282776278337
SENGERS SYNDROME	0.00111359	0.20703282776278337
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00111359	0.20703282776278337
GLUTAMINE DEFICIENCY, CONGENITAL	0.00111359	0.20703282776278337
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00111359	0.20703282776278337
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00111359	0.20703282776278337
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00111359	0.20703282776278337
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00111359	0.20703282776278337
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00111359	0.20703282776278337
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00111359	0.20703282776278337
ADDUCTED THUMBS SYNDROME	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00111359	0.20703282776278337
SOTOS SYNDROME 2	0.00111359	0.20703282776278337
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00111359	0.20703282776278337
EPISODIC ATAXIA, TYPE 6	0.00111359	0.20703282776278337
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00111359	0.20703282776278337
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00111359	0.20703282776278337
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00111359	0.20703282776278337
LATHOSTEROLOSIS	0.00111359	0.20703282776278337
XYLOSIDASE DEFICIENCY	0.00111359	0.20703282776278337
CHITAYAT SYNDROME	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00111359	0.20703282776278337
JACOBSEN SYNDROME	0.00111359	0.20703282776278337
OSTEOPENIA AND SPARSE HAIR	0.00111359	0.20703282776278337
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00111359	0.20703282776278337
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00111359	0.20703282776278337
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00111359	0.20703282776278337
PIERSON SYNDROME	0.00111359	0.20703282776278337
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00111359	0.20703282776278337
SIFRIM-HITZ-WEISS SYNDROME	0.00111359	0.20703282776278337
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00111359	0.20703282776278337
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00111359	0.20703282776278337
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00111359	0.20703282776278337
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00111359	0.20703282776278337
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00111359	0.20703282776278337
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00111359	0.20703282776278337
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00111359	0.20703282776278337
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00111359	0.20703282776278337
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00111359	0.20703282776278337
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00111359	0.20703282776278337
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00111359	0.20703282776278337
CHIARI MALFORMATION TYPE II	0.00111359	0.20703282776278337
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00111359	0.20703282776278337
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00111359	0.20703282776278337
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00111359	0.20703282776278337
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00111359	0.20703282776278337
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00111359	0.20703282776278337
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00111359	0.20703282776278337
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00111359	0.20703282776278337
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00111359	0.20703282776278337
LEGIUS SYNDROME	0.00111359	0.20703282776278337
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00111359	0.20703282776278337
DYSTONIA 11, MYOCLONIC	0.00111359	0.20703282776278337
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00111359	0.20703282776278337
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00111359	0.20703282776278337
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00111359	0.20703282776278337
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00111359	0.20703282776278337
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00111359	0.20703282776278337
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00111359	0.20703282776278337
MYOPATHY, CENTRONUCLEAR, 5	0.00111359	0.20703282776278337
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00111359	0.20703282776278337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00111359	0.20703282776278337
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00111359	0.20703282776278337
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00111359	0.20703282776278337
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.15689012720849968
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.15689012720849968
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.15689012720849968
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.15689012720849968
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.15689012720849968
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.15689012720849968
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000843882	0.15689012720849968
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000843882	0.15689012720849968
CULLER-JONES SYNDROME; CJS	0.000843882	0.15689012720849968
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.15689012720849968
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.15689012720849968
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.15689012720849968
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.15689012720849968
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000843882	0.15689012720849968
GLASS SYNDROME	0.000843882	0.15689012720849968
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000843882	0.15689012720849968
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000843882	0.15689012720849968
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.000843882	0.15689012720849968
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.15689012720849968
LOWRY-MACLEAN SYNDROME	0.000843882	0.15689012720849968
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.15689012720849968
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.000843882	0.15689012720849968
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.15689012720849968
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000843882	0.15689012720849968
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000843882	0.15689012720849968
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000843882	0.15689012720849968
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.15689012720849968
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.15689012720849968
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000843882	0.15689012720849968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000843882	0.15689012720849968
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.15689012720849968
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.000843882	0.15689012720849968
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.15689012720849968
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000843882	0.15689012720849968
OROTIC ACIDURIA	0.000843882	0.15689012720849968
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.15689012720849968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.15689012720849968
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.15689012720849968
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.15689012720849968
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000843882	0.15689012720849968
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.15689012720849968
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.15689012720849968
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000843882	0.15689012720849968
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.15689012720849968
#602398 DESMOSTEROLOSIS	0.000843882	0.15689012720849968
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.15689012720849968
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000843882	0.15689012720849968
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.15689012720849968
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.15689012720849968
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.15689012720849968
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000843882	0.15689012720849968
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000843882	0.15689012720849968
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.15689012720849968
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.15689012720849968
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000843882	0.15689012720849968
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.000843882	0.15689012720849968
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000843882	0.15689012720849968
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000843882	0.15689012720849968
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000843882	0.15689012720849968
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000843882	0.15689012720849968
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.15689012720849968
CHROMOSOME 19p13.13 DELETION SYNDROME	0.000843882	0.15689012720849968
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.15689012720849968
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.15689012720849968
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.15689012720849968
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.15689012720849968
Congenital disorder of glycosylation, type IIh	0.000843882	0.15689012720849968
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.15689012720849968
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.15689012720849968
ALAZAMI-YUAN SYNDROME	0.000843882	0.15689012720849968
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.15689012720849968
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000843882	0.15689012720849968
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.000843882	0.15689012720849968
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.15689012720849968
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.15689012720849968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.15689012720849968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.15689012720849968
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.15689012720849968
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.15689012720849968
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000843882	0.15689012720849968
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000843882	0.15689012720849968
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.15689012720849968
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.15689012720849968
FORSYTHE-WAKELING SYNDROME; FWS	0.000843882	0.15689012720849968
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000843882	0.15689012720849968
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.15689012720849968
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.000843882	0.15689012720849968
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.15689012720849968
PELLAGRA-LIKE SYNDROME	0.000843882	0.15689012720849968
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.15689012720849968
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.15689012720849968
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000843882	0.15689012720849968
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.000843882	0.15689012720849968
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.15689012720849968
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000843882	0.15689012720849968
Temtamy preaxial brachydactyly syndrome	0.000843882	0.15689012720849968
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.15689012720849968
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000843882	0.15689012720849968
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000843882	0.15689012720849968
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.15689012720849968
OGDEN SYNDROME; OGDNS	0.000843882	0.15689012720849968
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.15689012720849968
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000843882	0.15689012720849968
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.15689012720849968
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.15689012720849968
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.15689012720849968
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.000843882	0.15689012720849968
WAISMAN SYNDROME; WSMN	0.000843882	0.15689012720849968
NOONAN SYNDROME 9; NS9	0.000843882	0.15689012720849968
BAND HETEROTOPIA; BH	0.000843882	0.15689012720849968
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.15689012720849968
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.15689012720849968
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.15689012720849968
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000843882	0.15689012720849968
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.15689012720849968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.15689012720849968
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.000843882	0.15689012720849968
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.15689012720849968
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.15689012720849968
SECKEL SYNDROME 8; SCKL8	0.000843882	0.15689012720849968
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000843882	0.15689012720849968
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.15689012720849968
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000843882	0.15689012720849968
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000843882	0.15689012720849968
300270 ADRENOMYODYSTROPHY	0.000843882	0.15689012720849968
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000843882	0.15689012720849968
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000843882	0.15689012720849968
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.15689012720849968
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.15689012720849968
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.15689012720849968
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.000843882	0.15689012720849968
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000843882	0.15689012720849968
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.15689012720849968
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.15689012720849968
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.15689012720849968
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.000843882	0.15689012720849968
REVESZ SYNDROME	0.000843882	0.15689012720849968
BETA-UREIDOPROPIONASE DEFICIENCY	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000843882	0.15689012720849968
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.15689012720849968
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000843882	0.15689012720849968
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.15689012720849968
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.15689012720849968
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000843882	0.15689012720849968
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.15689012720849968
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.15689012720849968
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.15689012720849968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.15689012720849968
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.15689012720849968
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000843882	0.15689012720849968
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.15689012720849968
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.15689012720849968
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.15689012720849968
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000843882	0.15689012720849968
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000843882	0.15689012720849968
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.15689012720849968
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.15689012720849968
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.15689012720849968
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.15689012720849968
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.15689012720849968
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.15689012720849968
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.15689012720849968
LISSENCEPHALY 1; LIS1	0.000843882	0.15689012720849968
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000843882	0.15689012720849968
COFFIN-SIRIS SYNDROME 5	0.000843882	0.15689012720849968
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.15689012720849968
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.15689012720849968
STEEL SYNDROME; STLS	0.000843882	0.15689012720849968
OCULOECTODERMAL SYNDROME; OES	0.000843882	0.15689012720849968
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.15689012720849968
Bardet-Biedl syndrome 2	0.000843882	0.15689012720849968
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.15689012720849968
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000843882	0.15689012720849968
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000843882	0.15689012720849968
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000843882	0.15689012720849968
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000843882	0.15689012720849968
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.15689012720849968
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.15689012720849968
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.15689012720849968
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.000843882	0.15689012720849968
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.15689012720849968
NOONAN SYNDROME 3; NS3	0.000843882	0.15689012720849968
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000843882	0.15689012720849968
Cerebral creatine deficiency syndrome 2	0.000843882	0.15689012720849968
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.15689012720849968
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.15689012720849968
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.15689012720849968
CHAR SYNDROME	0.000843882	0.15689012720849968
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.15689012720849968
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.15689012720849968
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000843882	0.15689012720849968
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000843882	0.15689012720849968
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.15689012720849968
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.15689012720849968
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.15689012720849968
LISSENCEPHALY 8; LIS8	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000843882	0.15689012720849968
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.15689012720849968
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.15689012720849968
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000843882	0.15689012720849968
LISSENCEPHALY 2; LIS2	0.000843882	0.15689012720849968
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.15689012720849968
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.15689012720849968
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000843882	0.15689012720849968
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.15689012720849968
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000843882	0.15689012720849968
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.15689012720849968
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.15689012720849968
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000843882	0.15689012720849968
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000843882	0.15689012720849968
MACDERMOT-WINTER SYNDROME	0.000843882	0.15689012720849968
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.15689012720849968
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.15689012720849968
SENIOR-LOKEN SYNDROME 9	0.000843882	0.15689012720849968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.15689012720849968
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000843882	0.15689012720849968
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000843882	0.15689012720849968
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000843882	0.15689012720849968
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.15689012720849968
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.15689012720849968
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000843882	0.15689012720849968
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000843882	0.15689012720849968
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.15689012720849968
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.15689012720849968
PHACE ASSOCIATION	0.000843882	0.15689012720849968
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000843882	0.15689012720849968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED 103	0.000843882	0.15689012720849968
LISSENCEPHALY 4	0.000843882	0.15689012720849968
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.15689012720849968
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.15689012720849968
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000843882	0.15689012720849968
Jawad syndrome	0.000843882	0.15689012720849968
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000843882	0.15689012720849968
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000843882	0.15689012720849968
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.15689012720849968
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.15689012720849968
Retinitis pigmentosa with or without skeletal anomalies	0.000843882	0.15689012720849968
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.15689012720849968
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.15689012720849968
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000843882	0.15689012720849968
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000843882	0.15689012720849968
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000843882	0.15689012720849968
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.15689012720849968
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000843882	0.15689012720849968
CHROMOSOME 1p35 DELETION SYNDROME	0.000843882	0.15689012720849968
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.15689012720849968
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.15689012720849968
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.15689012720849968
NOONAN SYNDROME 5; NS5	0.000843882	0.15689012720849968
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.15689012720849968
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.15689012720849968
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.15689012720849968
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.15689012720849968
RAINE SYNDROME	0.000843882	0.15689012720849968
FRIAS SYNDROME	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000843882	0.15689012720849968
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000843882	0.15689012720849968
HOLOPROSENCEPHALY 11	0.000843882	0.15689012720849968
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000843882	0.15689012720849968
GLYCEROL KINASE DEFICIENCY; GKD	0.000843882	0.15689012720849968
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000843882	0.15689012720849968
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.15689012720849968
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.15689012720849968
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.15689012720849968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.15689012720849968
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.15689012720849968
FRONTOOCULAR SYNDROME	0.000843882	0.15689012720849968
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000843882	0.15689012720849968
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.000843882	0.15689012720849968
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000843882	0.15689012720849968
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000843882	0.15689012720849968
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.15689012720849968
HYPEREKPLEXIA 4; HKPX4	0.000843882	0.15689012720849968
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.15689012720849968
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000843882	0.15689012720849968
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.15689012720849968
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000843882	0.15689012720849968
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000843882	0.15689012720849968
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.000843882	0.15689012720849968
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.15689012720849968
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.15689012720849968
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000843882	0.15689012720849968
MECKEL SYNDROME 13; MKS13	0.000843882	0.15689012720849968
MEIER-GORLIN SYNDROME 7	0.000843882	0.15689012720849968
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.15689012720849968
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.15689012720849968
CURRARINO SYNDROME	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.15689012720849968
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000843882	0.15689012720849968
CURRY-JONES SYNDROME	0.000843882	0.15689012720849968
ALAZAMI SYNDROME; ALAZS	0.000843882	0.15689012720849968
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.15689012720849968
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.15689012720849968
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000843882	0.15689012720849968
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.000843882	0.15689012720849968
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.15689012720849968
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.15689012720849968
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.15689012720849968
WAARDENBURG-SHAH SYNDROME	0.000843882	0.15689012720849968
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.15689012720849968
NOONAN SYNDROME 2; NS2	0.000843882	0.15689012720849968
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000843882	0.15689012720849968
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.000843882	0.15689012720849968
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.15689012720849968
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000843882	0.15689012720849968
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.15689012720849968
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000843882	0.15689012720849968
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.15689012720849968
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.15689012720849968
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.000843882	0.15689012720849968
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.15689012720849968
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.15689012720849968
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.15689012720849968
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.000843882	0.15689012720849968
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.15689012720849968
Leukotriene C4 synthase deficiency	0.000843882	0.15689012720849968
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000843882	0.15689012720849968
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.15689012720849968
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000843882	0.15689012720849968
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.15689012720849968
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.15689012720849968
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000843882	0.15689012720849968
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000843882	0.15689012720849968
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.15689012720849968
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.15689012720849968
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.15689012720849968
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000843882	0.15689012720849968
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.15689012720849968
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.15689012720849968
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000843882	0.15689012720849968
#300555 DENT DISEASE 2	0.000843882	0.15689012720849968
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.15689012720849968
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.15689012720849968
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.15689012720849968
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000843882	0.15689012720849968
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.15689012720849968
HARTNUP DISORDER	0.000843882	0.15689012720849968
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000843882	0.15689012720849968
RAHMAN SYNDROME	0.000843882	0.15689012720849968
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.15689012720849968
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.15689012720849968
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.15689012720849968
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.15689012720849968
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000843882	0.15689012720849968
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.15689012720849968
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.15689012720849968
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.15689012720849968
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.15689012720849968
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.000843882	0.15689012720849968
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.15689012720849968
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.15689012720849968
KBG SYNDROME	0.000843882	0.15689012720849968
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.15689012720849968
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.15689012720849968
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.15689012720849968
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000843882	0.15689012720849968
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000843882	0.15689012720849968
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.15689012720849968
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.15689012720849968
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.15689012720849968
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.15689012720849968
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.15689012720849968
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000843882	0.15689012720849968
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.15689012720849968
SCHAAF-YANG SYNDROME; SHFYNG	0.000843882	0.15689012720849968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000843882	0.15689012720849968
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000843882	0.15689012720849968
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.15689012720849968
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.15689012720849968
PEHO-LIKE SYNDROME; PEHOL	0.000843882	0.15689012720849968
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.15689012720849968
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.15689012720849968
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.15689012720849968
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.15689012720849968
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000843882	0.15689012720849968
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.15689012720849968
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.15689012720849968
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.15689012720849968
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.15689012720849968
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000843882	0.15689012720849968
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000843882	0.15689012720849968
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.000843882	0.15689012720849968
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.15689012720849968
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.15689012720849968
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.15689012720849968
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000843882	0.15689012720849968
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.15689012720849968
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.15689012720849968
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.15689012720849968
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.15689012720849968
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.15689012720849968
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.15689012720849968
